ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||||||||||||||
mercury atom
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | A1BG | alpha-1-B glycoprotein |
|
affects expression | EXP | 19 | 58,858,172 | 58,864,865 | RGD:6480464 | CTD | |
| G | A2M | alpha-2-macroglobulin |
|
decreases expression | EXP | 12 | 9,220,304 | 9,268,558 | RGD:6480464 | CTD | |
| G | ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
increases expression | ISO | 16 | 16,043,434 | 16,236,931 | RGD:6480464 | CTD | |
| G | ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
multiple interactions | EXP | 10 | 101,542,463 | 101,611,662 | RGD:6480464 | CTD | |
| G | ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
|
increases expression | EXP | 21 | 43,619,799 | 43,717,354 | RGD:6480464 | CTD | |
| G | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 |
|
increases expression | EXP | 4 | 89,011,416 | 89,152,474 | RGD:6480464 | CTD | |
| G | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases expression | EXP | 9 | 133,589,268 | 133,763,062 | RGD:6480464 | CTD | |
| G | ACHE | acetylcholinesterase |
|
increases activity | EXP | 7 | 100,487,615 | 100,493,541 | RGD:6480464 | CTD | |
| G | ACP2 | acid phosphatase 2, lysosomal |
|
decreases expression | EXP | 11 | 47,260,853 | 47,270,457 | RGD:6480464 | CTD | |
| G | ACSL1 | acyl-CoA synthetase long-chain family member 1 |
|
decreases expression | EXP | 4 | 185,676,749 | 185,747,215 | RGD:6480464 | CTD | |
| G | ACTB | actin, beta |
|
increases expression | ISO | 7 | 5,566,779 | 5,570,232 | RGD:6480464 | CTD | |
| G | ADM | adrenomedullin |
|
increases expression | EXP | 11 | 10,326,642 | 10,328,923 | RGD:6480464 | CTD | |
| G | AHR | aryl hydrocarbon receptor |
|
multiple interactions | ISO | 7 | 17,338,276 | 17,385,775 | RGD:6480464 | CTD | |
| G | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) |
|
decreases expression | EXP | 7 | 134,127,107 | 134,143,888 | RGD:6480464 | CTD | |
| G | AKT1S1 | AKT1 substrate 1 (proline-rich) |
|
decreases expression | ISO | 19 | 50,372,296 | 50,380,644 | RGD:6480464 | CTD | |
| G | AKT2 | v-akt murine thymoma viral oncogene homolog 2 |
|
decreases expression | EXP | 19 | 40,736,224 | 40,791,302 | RGD:6480464 | CTD | |
| G | ALAD | aminolevulinate dehydratase |
|
multiple interactions | ISO | 9 | 116,148,592 | 116,163,618 | RGD:6480464 | CTD | |
| G | ALAD | aminolevulinate dehydratase |
|
decreases activity | ISO | 9 | 116,148,592 | 116,163,618 | RGD:6480464 | CTD | |
| G | ALAD | aminolevulinate dehydratase |
|
multiple interactions | ISO | 9 | 116,148,592 | 116,163,618 | RGD:6480464 | CTD | |
| G | ALDH6A1 | aldehyde dehydrogenase 6 family, member A1 |
|
decreases expression | EXP | 14 | 74,526,869 | 74,551,196 | RGD:6480464 | CTD | |
| G | ALG3 | ALG3, alpha-1,3- mannosyltransferase |
|
increases expression | EXP | 3 | 183,960,117 | 183,967,313 | RGD:6480464 | CTD | |
| G | ALS2 | amyotrophic lateral sclerosis 2 (juvenile) |
|
increases expression | EXP | 2 | 202,564,986 | 202,645,895 | RGD:6480464 | CTD | |
| G | ANK1 | ankyrin 1, erythrocytic |
|
decreases expression | EXP | 8 | 41,510,744 | 41,754,280 | RGD:6480464 | CTD | |
| G | ANKHD1 | ankyrin repeat and KH domain containing 1 |
|
increases expression | EXP | 5 | 139,781,399 | 139,919,441 | RGD:6480464 | CTD | |
| G | ANXA2 | annexin A2 |
|
increases expression | EXP | 15 | 60,639,350 | 60,690,185 | RGD:6480464 | CTD | |
| G | AP2A2 | adaptor-related protein complex 2, alpha 2 subunit |
|
decreases expression | EXP | 11 | 925,809 | 1,012,245 | RGD:6480464 | CTD | |
| G | APOA2 | apolipoprotein A-II |
|
affects expression | EXP | 1 | 161,192,083 | 161,193,418 | RGD:6480464 | CTD | |
| G | APOE | apolipoprotein E |
|
affects response to substance | EXP | 19 | 45,409,039 | 45,412,650 | RGD:6480464 | CTD | |
| G | APP | amyloid beta (A4) precursor protein |
|
multiple interactions | EXP | 21 | 27,252,861 | 27,543,446 | RGD:6480464 | CTD | |
| G | APP | amyloid beta (A4) precursor protein |
|
increases secretion | EXP | 21 | 27,252,861 | 27,543,446 | RGD:6480464 | CTD | |
| G | AQP10 | aquaporin 10 |
|
decreases activity | EXP | 1 | 154,293,592 | 154,297,801 | RGD:6480464 | CTD | |
| G | AQP10 | aquaporin 10 |
|
affects activity | EXP | 1 | 154,293,592 | 154,297,801 | RGD:6480464 | CTD | |
| G | AQP8 | aquaporin 8 |
|
multiple interactions | ISO | 16 | 25,228,285 | 25,240,253 | RGD:6480464 | CTD | |
| G | ARF4 | ADP-ribosylation factor 4 |
|
decreases expression | EXP | 3 | 57,557,090 | 57,583,215 | RGD:6480464 | CTD | |
| G | ARG1 | arginase, liver |
|
decreases activity | ISO | 6 | 131,894,344 | 131,905,472 | RGD:6480464 | CTD | |
| G | ARG2 | arginase, type II |
|
decreases activity | ISO | 14 | 68,086,579 | 68,118,437 | RGD:6480464 | CTD | |
| G | ARHGEF28 | Rho guanine nucleotide exchange factor (GEF) 28 |
|
decreases expression | EXP | 5 | 72,921,983 | 73,237,818 | RGD:6480464 | CTD | |
| G | ARID1A | AT rich interactive domain 1A (SWI-like) |
|
increases expression | EXP | 1 | 27,022,522 | 27,108,601 | RGD:6480464 | CTD | |
| G | ARNT | aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions | ISO | 1 | 150,782,181 | 150,849,244 | RGD:6480464 | CTD | |
| G | ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide |
|
increases expression | ISO | 3 | 141,595,470 | 141,645,382 | RGD:6480464 | CTD | |
| G | ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
|
decreases expression | EXP | 3 | 113,465,866 | 113,530,905 | RGD:6480464 | CTD | |
| G | AZGP1 | alpha-2-glycoprotein 1, zinc-binding |
|
decreases expression | EXP | 7 | 99,564,350 | 99,573,735 | RGD:6480464 | CTD | |
| G | BAD | BCL2-associated agonist of cell death |
|
decreases expression | EXP | 11 | 64,037,300 | 64,052,176 | RGD:6480464 | CTD | |
| G | BAG6 | BCL2-associated athanogene 6 |
|
decreases expression | EXP | 6 | 31,606,805 | 31,620,477 | RGD:6480464 | CTD | |
| G | BANK1 | B-cell scaffold protein with ankyrin repeats 1 |
|
increases expression | EXP | 4 | 102,711,764 | 102,995,969 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
increases expression | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
|
decreases expression | EXP | 2 | 111,878,491 | 111,926,022 | RGD:6480464 | CTD | |
| G | BCOR | BCL6 corepressor |
|
increases expression | EXP | X | 39,910,499 | 40,036,582 | RGD:6480464 | CTD | |
| G | BDNF | brain-derived neurotrophic factor |
|
decreases expression | EXP | 11 | 27,676,440 | 27,743,605 | RGD:6480464 | CTD | |
| G | BDNF | brain-derived neurotrophic factor |
|
affects response to substance | EXP | 11 | 27,676,440 | 27,743,605 | RGD:6480464 | CTD | |
| G | BHLHE40 | basic helix-loop-helix family, member e40 |
|
increases expression | EXP | 3 | 5,021,097 | 5,026,866 | RGD:6480464 | CTD | |
| G | BHLHE40 | basic helix-loop-helix family, member e40 |
|
increases expression | EXP | 3 | 5,021,097 | 5,026,866 | RGD:6480464 | CTD | |
| G | BIRC3 | baculoviral IAP repeat containing 3 |
|
increases expression | EXP | 11 | 102,188,181 | 102,210,134 | RGD:6480464 | CTD | |
| G | BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
increases expression | EXP | 2 | 203,241,050 | 203,432,474 | RGD:6480464 | CTD | |
| G | BRAF | v-raf murine sarcoma viral oncogene homolog B1 |
|
increases expression | EXP | 7 | 140,433,812 | 140,624,564 | RGD:6480464 | CTD | |
| G | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase |
|
increases expression | EXP | 2 | 111,395,409 | 111,435,684 | RGD:6480464 | CTD | |
| G | BUB3 | BUB3 mitotic checkpoint protein |
|
decreases expression | EXP | 10 | 124,913,760 | 124,924,886 | RGD:6480464 | CTD | |
| G | C3 | complement component 3 |
|
affects expression | EXP | 19 | 6,677,846 | 6,720,662 | RGD:6480464 | CTD | |
| G | C6 | complement component 6 |
|
affects expression | EXP | 5 | 41,142,336 | 41,261,540 | RGD:6480464 | CTD | |
| G | CA1 | carbonic anhydrase I |
|
decreases activity | EXP | 8 | 86,240,458 | 86,290,342 | RGD:6480464 | CTD | |
| G | CA2 | carbonic anhydrase II |
|
decreases activity | EXP | 8 | 86,376,131 | 86,393,721 | RGD:6480464 | CTD | |
| G | CA3 | carbonic anhydrase III, muscle specific |
|
increases expression | EXP | 8 | 86,351,056 | 86,361,269 | RGD:6480464 | CTD | |
| G | CADM1 | cell adhesion molecule 1 |
|
decreases expression | EXP | 11 | 115,044,345 | 115,375,241 | RGD:6480464 | CTD | |
| G | CALM3 | calmodulin 3 (phosphorylase kinase, delta) |
|
decreases expression | EXP | 19 | 47,104,512 | 47,114,039 | RGD:6480464 | CTD | |
| G | CAPZB | capping protein (actin filament) muscle Z-line, beta |
|
increases expression | EXP | 1 | 19,665,267 | 19,812,066 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
increases activity | EXP | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 1 | 15,818,769 | 15,851,285 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
decreases activity | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
multiple interactions | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CCL3 | chemokine (C-C motif) ligand 3 |
|
increases expression | ISO | 17 | 34,415,602 | 34,417,506 | RGD:6480464 | CTD | |
| G | CCNB2 | cyclin B2 |
|
increases expression | EXP | 15 | 59,397,284 | 59,417,244 | RGD:6480464 | CTD | |
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
decreases expression | EXP | 3 | 46,395,235 | 46,402,413 | RGD:6480464 | CTD | |
| G | CD226 | CD226 molecule |
|
increases expression | EXP | 18 | 67,530,192 | 67,624,232 | RGD:6480464 | CTD | |
| G | CD40 | CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression | EXP | 20 | 44,746,906 | 44,758,384 | RGD:6480464 | CTD | |
| G | CD84 | CD84 molecule |
|
decreases expression | EXP | 1 | 160,510,884 | 160,549,306 | RGD:6480464 | CTD | |
| G | CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
increases expression | EXP | 17 | 30,814,105 | 30,818,271 | RGD:6480464 | CTD | |
| G | CDKN3 | cyclin-dependent kinase inhibitor 3 |
|
increases expression | EXP | 14 | 54,863,673 | 54,886,936 | RGD:6480464 | CTD | |
| G | CEBPD | CCAAT/enhancer binding protein (C/EBP), delta |
|
decreases expression | EXP | 8 | 48,649,476 | 48,650,726 | RGD:6480464 | CTD | |
| G | CFB | complement factor B |
|
decreases expression | EXP | 6 | 31,913,721 | 31,919,861 | RGD:6480464 | CTD | |
| G | CFB | complement factor B |
|
affects expression | EXP | 6 | 31,913,721 | 31,919,861 | RGD:6480464 | CTD | |
| G | CFD | complement factor D (adipsin) |
|
increases expression | EXP | 19 | 859,665 | 863,624 | RGD:6480464 | CTD | |
| G | CIDEB | cell death-inducing DFFA-like effector b |
|
decreases expression | EXP | 14 | 24,774,393 | 24,780,576 | RGD:6480464 | CTD | |
| G | CKS2 | CDC28 protein kinase regulatory subunit 2 |
|
increases expression | EXP | 9 | 91,926,113 | 91,931,618 | RGD:6480464 | CTD | |
| G | CLASP2 | cytoplasmic linker associated protein 2 |
|
increases expression | EXP | 3 | 33,537,737 | 33,759,705 | RGD:6480464 | CTD | |
| G | CLGN | calmegin |
|
decreases expression | EXP | 4 | 141,309,607 | 141,348,815 | RGD:6480464 | CTD | |
| G | CLK1 | CDC-like kinase 1 |
|
affects expression | EXP | 2 | 201,717,732 | 201,729,467 | RGD:6480464 | CTD | |
| G | CLPTM1 | cleft lip and palate associated transmembrane protein 1 |
|
decreases expression | EXP | 19 | 45,457,842 | 45,496,604 | RGD:6480464 | CTD | |
| G | CLPTM1 | cleft lip and palate associated transmembrane protein 1 |
|
increases expression | EXP | 19 | 45,457,842 | 45,496,604 | RGD:6480464 | CTD | |
| G | CLTC | clathrin, heavy chain (Hc) |
|
decreases expression | EXP | 17 | 57,697,050 | 57,774,317 | RGD:6480464 | CTD | |
| G | CNOT3 | CCR4-NOT transcription complex, subunit 3 |
|
increases expression | EXP | 19 | 54,641,436 | 54,659,446 | RGD:6480464 | CTD | |
| G | COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) |
|
increases expression | EXP | 2 | 228,029,281 | 228,179,508 | RGD:6480464 | CTD | |
| G | COMT | catechol-O-methyltransferase |
|
affects response to substance | EXP | 22 | 19,929,263 | 19,957,498 | RGD:6480464 | CTD | |
| G | CP | ceruloplasmin (ferroxidase) |
|
affects expression | EXP | 3 | 148,880,197 | 148,939,832 | RGD:6480464 | CTD | |
| G | CPN2 | carboxypeptidase N, polypeptide 2 |
|
affects expression | EXP | 3 | 194,060,494 | 194,072,057 | RGD:6480464 | CTD | |
| G | CPOX | coproporphyrinogen oxidase |
|
affects response to substance | EXP | 3 | 98,298,290 | 98,312,455 | RGD:6480464 | CTD | |
| G | CPOX | coproporphyrinogen oxidase |
|
multiple interactions | EXP | 3 | 98,298,290 | 98,312,455 | RGD:6480464 | CTD | |
| G | CPOX | coproporphyrinogen oxidase |
|
decreases activity | EXP | 3 | 98,298,290 | 98,312,455 | RGD:6480464 | CTD | |
| G | CPOX | coproporphyrinogen oxidase |
|
decreases activity | EXP | 3 | 98,298,290 | 98,312,455 | RGD:6480464 | CTD | |
| G | CPOX | coproporphyrinogen oxidase |
|
multiple interactions | EXP | 3 | 98,298,290 | 98,312,455 | RGD:6480464 | CTD | |
| G | CPOX | coproporphyrinogen oxidase |
|
affects response to substance | EXP | 3 | 98,298,290 | 98,312,455 | RGD:6480464 | CTD | |
| G | CPZ | carboxypeptidase Z |
|
increases expression | EXP | 4 | 8,594,387 | 8,621,488 | RGD:6480464 | CTD | |
| G | CRYAA | crystallin, alpha A |
|
decreases expression | EXP | 21 | 44,589,141 | 44,592,913 | RGD:6480464 | CTD | |
| G | CRYAB | crystallin, alpha B |
|
multiple interactions | ISO | 11 | 111,779,350 | 111,782,473 | RGD:6480464 | CTD | |
| G | CRYAB | crystallin, alpha B |
|
decreases response to substance | ISO | 11 | 111,779,350 | 111,782,473 | RGD:6480464 | CTD | |
| G | CRYAB | crystallin, alpha B |
|
increases expression | ISO | 11 | 111,779,350 | 111,782,473 | RGD:6480464 | CTD | |
| G | CRYZ | crystallin, zeta (quinone reductase) |
|
multiple interactions | ISO | 1 | 75,171,170 | 75,199,092 | RGD:6480464 | CTD | |
| G | CRYZ | crystallin, zeta (quinone reductase) |
|
increases activity | ISO | 1 | 75,171,170 | 75,199,092 | RGD:6480464 | CTD | |
| G | CSPG5 | chondroitin sulfate proteoglycan 5 (neuroglycan C) |
|
increases expression | EXP | 3 | 47,603,728 | 47,621,730 | RGD:6480464 | CTD | |
| G | CSRNP2 | cysteine-serine-rich nuclear protein 2 |
|
increases expression | EXP | 12 | 51,454,988 | 51,477,454 | RGD:6480464 | CTD | |
| G | CTBP1 | C-terminal binding protein 1 |
|
increases expression | EXP | 4 | 1,205,228 | 1,242,908 | RGD:6480464 | CTD | |
| G | CXCL5 | chemokine (C-X-C motif) ligand 5 |
|
increases expression | ISO | 4 | 74,861,359 | 74,864,416 | RGD:6480464 | CTD | |
| G | CYB561 | cytochrome b561 |
|
decreases expression | EXP | 17 | 61,509,665 | 61,523,722 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases expression | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases stability | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases expression | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases activity | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases expression | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases expression | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
increases activity | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
multiple interactions | ISO | 2 | 38,294,746 | 38,303,323 | RGD:6480464 | CTD | |
| G | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
increases expression | ISO | 2 | 38,294,746 | 38,303,323 | RGD:6480464 | CTD | |
| G | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
multiple interactions | ISO | 2 | 38,294,746 | 38,303,323 | RGD:6480464 | CTD | |
| G | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
increases expression | ISO | 2 | 38,294,746 | 38,303,323 | RGD:6480464 | CTD | |
| G | CYP2U1 | cytochrome P450, family 2, subfamily U, polypeptide 1 |
|
increases expression | EXP | 4 | 108,852,717 | 108,874,613 | RGD:6480464 | CTD | |
| G | DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) |
|
increases expression | EXP | 1 | 57,463,579 | 58,716,211 | RGD:6480464 | CTD | |
| G | DEF8 | differentially expressed in FDCP 8 homolog (mouse) |
|
decreases expression | ISO | 16 | 90,015,139 | 90,034,468 | RGD:6480464 | CTD | |
| G | DIRAS1 | DIRAS family, GTP-binding RAS-like 1 |
|
decreases expression | EXP | 19 | 2,714,565 | 2,721,390 | RGD:6480464 | CTD | |
| G | DNAH1 | dynein, axonemal, heavy chain 1 |
|
decreases expression | EXP | 3 | 52,350,335 | 52,434,513 | RGD:6480464 | CTD | |
| G | DNAJA2 | DnaJ (Hsp40) homolog, subfamily A, member 2 |
|
increases expression | ISO | 16 | 46,989,274 | 47,007,625 | RGD:6480464 | CTD | |
| G | DOCK10 | dedicator of cytokinesis 10 |
|
increases expression | EXP | 2 | 225,629,807 | 225,907,330 | RGD:6480464 | CTD | |
| G | DPYSL4 | dihydropyrimidinase-like 4 |
|
increases expression | EXP | 10 | 134,000,414 | 134,019,280 | RGD:6480464 | CTD | |
| G | DRD3 | dopamine receptor D3 |
|
multiple interactions | ISO | 3 | 113,847,557 | 113,897,899 | RGD:6480464 | CTD | |
| G | DRD4 | dopamine receptor D4 |
|
multiple interactions | ISO | 11 | 637,305 | 640,706 | RGD:6480464 | CTD | |
| G | DTNA | dystrobrevin, alpha |
|
increases expression | EXP | 18 | 32,073,254 | 32,471,808 | RGD:6480464 | CTD | |
| G | EEA1 | early endosome antigen 1 |
|
increases expression | EXP | 12 | 93,166,285 | 93,323,107 | RGD:6480464 | CTD | |
| G | EFNB1 | ephrin-B1 |
|
increases expression | EXP | X | 68,048,840 | 68,062,007 | RGD:6480464 | CTD | |
| G | EIF2AK1 | eukaryotic translation initiation factor 2-alpha kinase 1 |
|
multiple interactions | ISO | 7 | 6,061,878 | 6,098,860 | RGD:6480464 | CTD | |
| G | EIF2AK1 | eukaryotic translation initiation factor 2-alpha kinase 1 |
|
decreases activity | ISO | 7 | 6,061,878 | 6,098,860 | RGD:6480464 | CTD | |
| G | EIF3F | eukaryotic translation initiation factor 3, subunit F |
|
decreases expression | EXP | 11 | 8,008,867 | 8,017,718 | RGD:6480464 | CTD | |
| G | EMX2 | empty spiracles homeobox 2 |
|
increases expression | EXP | 10 | 119,301,956 | 119,309,057 | RGD:6480464 | CTD | |
| G | EN1 | engrailed homeobox 1 |
|
increases expression | EXP | 2 | 119,599,747 | 119,605,759 | RGD:6480464 | CTD | |
| G | ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
increases expression | EXP | 6 | 132,129,156 | 132,216,295 | RGD:6480464 | CTD | |
| G | ESR2 | estrogen receptor 2 (ER beta) |
|
increases expression | EXP | 14 | 64,693,751 | 64,805,268 | RGD:6480464 | CTD | |
| G | ETFB | electron-transfer-flavoprotein, beta polypeptide |
|
increases expression | EXP | 19 | 51,848,409 | 51,869,672 | RGD:6480464 | CTD | |
| G | ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
increases expression | EXP | 21 | 40,177,231 | 40,196,879 | RGD:6480464 | CTD | |
| G | EZH1 | enhancer of zeste homolog 1 (Drosophila) |
|
increases expression | EXP | 17 | 40,852,293 | 40,897,071 | RGD:6480464 | CTD | |
| G | F10 | coagulation factor X |
|
decreases expression | EXP | 13 | 113,777,113 | 113,803,843 | RGD:6480464 | CTD | |
| G | F5 | coagulation factor V (proaccelerin, labile factor) |
|
decreases expression | EXP | 1 | 169,481,192 | 169,555,769 | RGD:6480464 | CTD | |
| G | FABP5 | fatty acid binding protein 5 (psoriasis-associated) |
|
increases expression | ISO | 8 | 82,192,718 | 82,197,012 | RGD:6480464 | CTD | |
| G | FABP7 | fatty acid binding protein 7, brain |
|
increases expression | EXP | 6 | 123,100,646 | 123,105,219 | RGD:6480464 | CTD | |
| G | FAM106A | family with sequence similarity 106, member A |
|
increases expression | EXP | 17 | 18,427,880 | 18,430,160 | RGD:6480464 | CTD | |
| G | FAS | Fas (TNF receptor superfamily, member 6) |
|
multiple interactions | EXP | 10 | 90,750,288 | 90,775,542 | RGD:6480464 | CTD | |
| G | FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
affects response to substance | ISO | 1 | 161,185,087 | 161,189,038 | RGD:6480464 | CTD | |
| G | FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
|
decreases expression | EXP | 1 | 161,511,549 | 161,520,413 | RGD:6480464 | CTD | |
| G | FCRLA | Fc receptor-like A |
|
decreases expression | EXP | 1 | 161,676,762 | 161,684,142 | RGD:6480464 | CTD | |
| G | FERD3L | Fer3-like (Drosophila) |
|
decreases expression | EXP | 7 | 19,184,405 | 19,185,044 | RGD:6480464 | CTD | |
| G | FGF2 | fibroblast growth factor 2 (basic) |
|
increases expression | EXP | 4 | 123,747,863 | 123,819,390 | RGD:6480464 | CTD | |
| G | FLNB | filamin B, beta |
|
increases expression | EXP | 3 | 57,994,127 | 58,157,982 | RGD:6480464 | CTD | |
| G | FN1 | fibronectin 1 |
|
decreases expression | EXP | 2 | 216,225,177 | 216,300,791 | RGD:6480464 | CTD | |
| G | FOS | FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions | ISO | 14 | 75,745,481 | 75,748,937 | RGD:6480464 | CTD | |
| G | FOSL1 | FOS-like antigen 1 |
|
increases expression | EXP | 11 | 65,659,692 | 65,667,997 | RGD:6480464 | CTD | |
| G | FOXI1 | forkhead box I1 |
|
decreases expression | EXP | 5 | 169,532,917 | 169,536,729 | RGD:6480464 | CTD | |
| G | FOXK1 | forkhead box K1 |
|
increases expression | EXP | 7 | 4,721,930 | 4,811,074 | RGD:6480464 | CTD | |
| G | FURIN | furin (paired basic amino acid cleaving enzyme) |
|
decreases expression | EXP | 15 | 91,411,885 | 91,426,687 | RGD:6480464 | CTD | |
| G | G6PD | glucose-6-phosphate dehydrogenase |
|
decreases activity | EXP | X | 153,759,606 | 153,775,787 | RGD:6480464 | CTD | |
| G | GABRA6 | gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
|
increases expression | EXP | 5 | 161,112,658 | 161,129,598 | RGD:6480464 | CTD | |
| G | GAS7 | growth arrest-specific 7 |
|
increases expression | EXP | 17 | 9,813,926 | 10,101,868 | RGD:6480464 | CTD | |
| G | GCLC | glutamate-cysteine ligase, catalytic subunit |
|
increases expression | EXP | 6 | 53,362,139 | 53,409,927 | RGD:6480464 | CTD | |
| G | GCLC | glutamate-cysteine ligase, catalytic subunit |
|
affects response to substance | EXP | 6 | 53,362,139 | 53,409,927 | RGD:6480464 | CTD | |
| G | GCLC | glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions | EXP | 6 | 53,362,139 | 53,409,927 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
decreases expression | EXP | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
affects abundance | EXP | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
affects metabolic processing | EXP | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
affects abundance | EXP | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GGCX | gamma-glutamyl carboxylase |
|
decreases expression | EXP | 2 | 85,771,978 | 85,788,657 | RGD:6480464 | CTD | |
| G | GGT1 | gamma-glutamyltransferase 1 |
|
decreases expression | EXP | 22 | 24,979,718 | 25,024,972 | RGD:6480464 | CTD | |
| G | GLA | galactosidase, alpha |
|
increases expression | EXP | X | 100,652,779 | 100,663,001 | RGD:6480464 | CTD | |
| G | GLRA3 | glycine receptor, alpha 3 |
|
increases expression | EXP | 4 | 175,563,198 | 175,750,465 | RGD:6480464 | CTD | |
| G | GNGT1 | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 |
|
increases expression | EXP | 7 | 93,535,820 | 93,540,485 | RGD:6480464 | CTD | |
| G | GNLY | granulysin |
|
increases expression | EXP | 2 | 85,921,414 | 85,925,875 | RGD:6480464 | CTD | |
| G | GNRH1 | gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
increases expression | EXP | 8 | 25,276,774 | 25,282,556 | RGD:6480464 | CTD | |
| G | GPER | G protein-coupled estrogen receptor 1 |
|
decreases expression | EXP | 7 | 1,126,443 | 1,133,451 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
affects response to substance | EXP | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GSN | gelsolin |
|
decreases expression | EXP | 9 | 124,030,380 | 124,095,120 | RGD:6480464 | CTD | |
| G | GSN | gelsolin |
|
affects expression | EXP | 9 | 124,030,380 | 124,095,120 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
decreases activity | EXP | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSS | glutathione synthetase |
|
affects abundance | EXP | 20 | 33,516,236 | 33,543,601 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
multiple interactions | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
increases expression | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
multiple interactions | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
increases expression | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
increases expression | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
affects abundance | EXP | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
affects activity | ISO | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
multiple interactions | ISO | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
increases expression | ISO | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
affects response to substance | EXP | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
affects response to substance | EXP | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
multiple interactions | EXP | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
affects abundance | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
increases expression | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
increases expression | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
affects abundance | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
multiple interactions | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
affects abundance | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTT1 | glutathione S-transferase theta 1 |
|
affects response to substance | EXP | 22 | 24,376,139 | 24,384,284 | RGD:6480464 | CTD | |
| G | GSTT1 | glutathione S-transferase theta 1 |
|
affects abundance | EXP | 22 | 24,376,139 | 24,384,284 | RGD:6480464 | CTD | |
| G | GSTT1 | glutathione S-transferase theta 1 |
|
affects response to substance | EXP | 22 | 24,376,139 | 24,384,284 | RGD:6480464 | CTD | |
| G | GSTT1 | glutathione S-transferase theta 1 |
|
multiple interactions | EXP | 22 | 24,376,139 | 24,384,284 | RGD:6480464 | CTD | |
| G | HABP4 | hyaluronan binding protein 4 |
|
increases expression | EXP | 9 | 99,212,414 | 99,253,618 | RGD:6480464 | CTD | |
| G | HAVCR1 | hepatitis A virus cellular receptor 1 |
|
increases expression | ISO | 5 | 156,456,531 | 156,485,970 | RGD:6480464 | CTD | |
| G | HDGFP1 | hepatoma-derived growth factor pseudogene 1 |
|
decreases expression | EXP | X | 130,780,649 | 130,782,246 | RGD:6480464 | CTD | |
| G | HEPH | hephaestin |
|
increases expression | EXP | X | 65,382,433 | 65,487,231 | RGD:6480464 | CTD | |
| G | HIF3A | hypoxia inducible factor 3, alpha subunit |
|
decreases expression | EXP | 19 | 46,800,303 | 46,846,690 | RGD:6480464 | CTD | |
| G | HIST1H2AG | histone cluster 1, H2ag |
|
increases expression | EXP | 6 | 27,100,817 | 27,101,314 | RGD:6480464 | CTD | |
| G | HIST1H3I | histone cluster 1, H3i |
|
increases expression | EXP | 6 | 27,839,623 | 27,840,099 | RGD:6480464 | CTD | |
| G | HIST1H4C | histone cluster 1, H4c |
|
increases expression | EXP | 6 | 26,104,176 | 26,104,565 | RGD:6480464 | CTD | |
| G | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
|
decreases expression | EXP | 6 | 32,605,183 | 32,611,429 | RGD:6480464 | CTD | |
| G | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
|
decreases expression | EXP | 6 | 32,605,183 | 32,611,429 | RGD:6480464 | CTD | |
| G | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
|
increases expression | EXP | 6 | 32,627,241 | 32,634,466 | RGD:6480464 | CTD | |
| G | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
|
decreases expression | EXP | 6 | 32,627,241 | 32,634,466 | RGD:6480464 | CTD | |
| G | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
|
increases expression | ISO | 6 | 32,627,241 | 32,634,466 | RGD:6480464 | CTD | |
| G | HMGN2 | high mobility group nucleosomal binding domain 2 |
|
increases expression | EXP | 1 | 26,798,902 | 26,803,133 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HNF1A | HNF1 homeobox A |
|
increases expression | EXP | 12 | 121,416,549 | 121,440,315 | RGD:6480464 | CTD | |
| G | HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) |
|
increases expression | EXP | 10 | 70,091,768 | 70,102,953 | RGD:6480464 | CTD | |
| G | HOXB4 | homeobox B4 |
|
increases expression | EXP | 17 | 46,652,869 | 46,655,743 | RGD:6480464 | CTD | |
| G | HOXB6 | homeobox B6 |
|
increases expression | EXP | 17 | 46,673,099 | 46,682,334 | RGD:6480464 | CTD | |
| G | HPX | hemopexin |
|
affects expression | EXP | 11 | 6,452,268 | 6,462,254 | RGD:6480464 | CTD | |
| G | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions | ISO | 11 | 532,242 | 535,550 | RGD:6480464 | CTD | |
| G | HS1BP3 | HCLS1 binding protein 3 |
|
decreases expression | EXP | 2 | 20,817,564 | 20,850,864 | RGD:6480464 | CTD | |
| G | HSF1 | heat shock transcription factor 1 |
|
multiple interactions | EXP | 8 | 145,515,270 | 145,538,385 | RGD:6480464 | CTD | |
| G | HSF1 | heat shock transcription factor 1 |
|
increases activity | EXP | 8 | 145,515,270 | 145,538,385 | RGD:6480464 | CTD | |
| G | HSF2 | heat shock transcription factor 2 |
|
decreases expression | ISO | 6 | 122,720,696 | 122,754,264 | RGD:6480464 | CTD | |
| G | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
increases expression | EXP | 14 | 102,547,075 | 102,606,086 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
multiple interactions | EXP | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
increases expression | EXP | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
multiple interactions | ISO | 9 | 127,997,127 | 128,003,666 | RGD:6480464 | CTD | |
| G | HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
affects expression | ISO | 9 | 127,997,127 | 128,003,666 | RGD:6480464 | CTD | |
| G | HSPD1 | heat shock 60kDa protein 1 (chaperonin) |
|
increases expression | ISO | 2 | 198,351,308 | 198,364,998 | RGD:6480464 | CTD | |
| G | HTN1 | histatin 1 |
|
increases expression | EXP | 4 | 70,916,159 | 70,924,559 | RGD:6480464 | CTD | |
| G | HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
|
increases expression | EXP | 10 | 92,500,575 | 92,617,671 | RGD:6480464 | CTD | |
| G | IFNA8 | interferon, alpha 8 |
|
increases expression | EXP | 9 | 21,409,146 | 21,410,184 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
affects expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
decreases secretion | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
affects expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | EXP | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNGR1 | interferon gamma receptor 1 |
|
affects response to substance | ISO | 6 | 137,518,621 | 137,540,567 | RGD:6480464 | CTD | |
| G | IFRD1 | interferon-related developmental regulator 1 |
|
decreases expression | EXP | 7 | 112,063,199 | 112,117,258 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions | EXP | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IKBKAP | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein |
|
decreases expression | EXP | 9 | 111,629,800 | 111,696,608 | RGD:6480464 | CTD | |
| G | IL10 | interleukin 10 |
|
increases expression | ISO | 1 | 206,940,948 | 206,945,839 | RGD:6480464 | CTD | |
| G | IL17RB | interleukin 17 receptor B |
|
decreases expression | EXP | 3 | 53,880,577 | 53,899,827 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
increases expression | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
increases expression | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL3RA | interleukin 3 receptor, alpha (low affinity) |
|
decreases expression | EXP | X Y |
1,455,509 1,405,509 |
1,501,582 1,451,582 |
RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
decreases secretion | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
increases expression | EXP | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IMPG1 | interphotoreceptor matrix proteoglycan 1 |
|
increases expression | EXP | 6 | 76,631,062 | 76,782,335 | RGD:6480464 | CTD | |
| G | IRF1 | interferon regulatory factor 1 |
|
affects response to substance | ISO | 5 | 131,817,301 | 131,826,465 | RGD:6480464 | CTD | |
| G | ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
|
increases activity | ISO | 10 | 33,189,246 | 33,247,293 | RGD:6480464 | CTD | |
| G | ITGB3BP | integrin beta 3 binding protein (beta3-endonexin) |
|
increases expression | EXP | 1 | 63,906,441 | 63,988,944 | RGD:6480464 | CTD | |
| G | ITIH1 | inter-alpha-trypsin inhibitor heavy chain 1 |
|
affects expression | EXP | 3 | 52,811,602 | 52,826,084 | RGD:6480464 | CTD | |
| G | ITIH3 | inter-alpha-trypsin inhibitor heavy chain 3 |
|
decreases expression | EXP | 3 | 52,828,784 | 52,843,025 | RGD:6480464 | CTD | |
| G | ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
affects expression | EXP | 3 | 52,847,006 | 52,864,717 | RGD:6480464 | CTD | |
| G | IVNS1ABP | influenza virus NS1A binding protein |
|
decreases expression | EXP | 1 | 185,265,520 | 185,286,461 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
decreases expression | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | KCNH2 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
increases expression | EXP | 7 | 150,642,044 | 150,675,402 | RGD:6480464 | CTD | |
| G | KIAA0226L | KIAA0226-like |
|
increases expression | EXP | 13 | 46,916,136 | 46,961,635 | RGD:6480464 | CTD | |
| G | KIAA0754 | KIAA0754 |
|
increases expression | EXP | 1 | 39,875,176 | 39,882,154 | RGD:6480464 | CTD | |
| G | KLF12 | Kruppel-like factor 12 |
|
decreases expression | EXP | 13 | 74,260,149 | 74,708,066 | RGD:6480464 | CTD | |
| G | KLF2 | Kruppel-like factor 2 (lung) |
|
decreases expression | EXP | 19 | 16,435,651 | 16,438,345 | RGD:6480464 | CTD | |
| G | KMT2B | lysine (K)-specific methyltransferase 2B |
|
increases expression | EXP | 19 | 36,208,921 | 36,229,779 | RGD:6480464 | CTD | |
| G | KRT1 | keratin 1 |
|
increases expression | EXP | 12 | 53,068,520 | 53,074,191 | RGD:6480464 | CTD | |
| G | LAMB4 | laminin, beta 4 |
|
increases expression | EXP | 7 | 107,663,996 | 107,770,801 | RGD:6480464 | CTD | |
| G | LANCL1 | LanC lantibiotic synthetase component C-like 1 (bacterial) |
|
decreases expression | EXP | 2 | 211,295,973 | 211,341,499 | RGD:6480464 | CTD | |
| G | LANCL2 | LanC lantibiotic synthetase component C-like 2 (bacterial) |
|
decreases expression | EXP | 7 | 55,433,141 | 55,501,435 | RGD:6480464 | CTD | |
| G | LEPR | leptin receptor |
|
decreases expression | EXP | 1 | 65,886,335 | 66,103,176 | RGD:6480464 | CTD | |
| G | LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 |
|
decreases expression | EXP | 19 | 55,085,257 | 55,099,027 | RGD:6480464 | CTD | |
| G | LIPA | lipase A, lysosomal acid, cholesterol esterase |
|
decreases expression | EXP | 10 | 90,973,326 | 91,011,660 | RGD:6480464 | CTD | |
| G | LMNA | lamin A/C |
|
decreases expression | EXP | 1 | 156,052,369 | 156,109,880 | RGD:6480464 | CTD | |
| G | LPPR4 | lipid phosphate phosphatase-related protein type 4 |
|
increases expression | EXP | 1 | 99,729,848 | 99,775,140 | RGD:6480464 | CTD | |
| G | LRRFIP1 | leucine rich repeat (in FLII) interacting protein 1 |
|
increases expression | EXP | 2 | 238,536,224 | 238,690,290 | RGD:6480464 | CTD | |
| G | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression | EXP | 22 | 38,597,939 | 38,612,518 | RGD:6480464 | CTD | |
| G | MAGEB4 | melanoma antigen family B, 4 |
|
increases expression | EXP | X | 30,260,057 | 30,262,310 | RGD:6480464 | CTD | |
| G | MAP2K2 | mitogen-activated protein kinase kinase 2 |
|
increases expression | EXP | 19 | 4,090,319 | 4,124,126 | RGD:6480464 | CTD | |
| G | MAP9 | microtubule-associated protein 9 |
|
increases expression | EXP | 4 | 156,263,810 | 156,298,122 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
increases phosphorylation | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
increases phosphorylation | ISO | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MCM2 | minichromosome maintenance complex component 2 |
|
increases expression | EXP | 3 | 127,317,253 | 127,341,279 | RGD:6480464 | CTD | |
| G | MED16 | mediator complex subunit 16 |
|
increases expression | EXP | 19 | 867,962 | 893,218 | RGD:6480464 | CTD | |
| G | MEOX2 | mesenchyme homeobox 2 |
|
increases expression | EXP | 7 | 15,650,837 | 15,726,308 | RGD:6480464 | CTD | |
| G | MFAP5 | microfibrillar associated protein 5 |
|
increases expression | EXP | 12 | 8,798,540 | 8,815,433 | RGD:6480464 | CTD | |
| G | MGAT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
decreases expression | EXP | 14 | 50,087,489 | 50,090,199 | RGD:6480464 | CTD | |
| G | MGAT5 | mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
|
increases expression | ISO | 2 | 135,011,830 | 135,212,192 | RGD:6480464 | CTD | |
| G | MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
|
multiple interactions | EXP | 16 | 55,513,081 | 55,540,586 | RGD:6480464 | CTD | |
| G | MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
affects response to substance | EXP | 20 | 44,637,547 | 44,645,200 | RGD:6480464 | CTD | |
| G | MORF4L2 | mortality factor 4 like 2 |
|
decreases expression | EXP | X | 102,930,426 | 102,943,086 | RGD:6480464 | CTD | |
| G | MPO | myeloperoxidase |
|
decreases activity | EXP | 17 | 56,347,217 | 56,358,296 | RGD:6480464 | CTD | |
| G | MSH6 | mutS homolog 6 (E. coli) |
|
increases expression | EXP | 2 | 48,010,221 | 48,034,092 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
affects binding | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases response to substance | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
multiple interactions | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
affects abundance | EXP | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
affects abundance | EXP | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT1E | metallothionein 1E |
|
affects response to substance | EXP | 16 | 56,659,585 | 56,661,024 | RGD:6480464 | CTD | |
| G | MT1H | metallothionein 1H |
|
increases expression | EXP | 16 | 56,703,726 | 56,705,041 | RGD:6480464 | CTD | |
| G | MT1M | metallothionein 1M |
|
affects abundance | EXP | 16 | 56,666,534 | 56,667,898 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
affects binding | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases response to substance | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
multiple interactions | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
affects abundance | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
increases expression | ISO | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
affects binding | ISO | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
increases expression | ISO | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
increases expression | ISO | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MT3 | metallothionein 3 |
|
increases expression | ISO | 16 | 56,623,267 | 56,625,000 | RGD:6480464 | CTD | |
| G | MT4 | metallothionein 4 |
|
affects abundance | EXP | 16 | 56,598,961 | 56,602,869 | RGD:6480464 | CTD | |
| G | MTF1 | metal-regulatory transcription factor 1 |
|
increases expression | EXP | 1 | 38,275,239 | 38,325,292 | RGD:6480464 | CTD | |
| G | MTMR11 | myotubularin related protein 11 |
|
decreases expression | EXP | 1 | 149,900,543 | 149,908,791 | RGD:6480464 | CTD | |
| G | MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase |
|
multiple interactions | EXP | 1 | 236,958,581 | 237,067,281 | RGD:6480464 | CTD | |
| G | MTRF1 | mitochondrial translational release factor 1 |
|
decreases expression | EXP | 13 | 41,790,516 | 41,837,713 | RGD:6480464 | CTD | |
| G | MVB12B | multivesicular body subunit 12B |
|
increases expression | EXP | 9 | 129,089,123 | 129,269,320 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
decreases expression | EXP | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
affects expression | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYO1B | myosin IB |
|
increases expression | EXP | 2 | 192,110,107 | 192,290,115 | RGD:6480464 | CTD | |
| G | NAP1L1 | nucleosome assembly protein 1-like 1 |
|
increases expression | EXP | 12 | 76,438,672 | 76,478,738 | RGD:6480464 | CTD | |
| G | NAT1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
multiple interactions | EXP | 8 | 18,027,971 | 18,081,198 | RGD:6480464 | CTD | |
| G | NAV3 | neuron navigator 3 |
|
increases expression | EXP | 12 | 78,225,069 | 78,606,790 | RGD:6480464 | CTD | |
| G | NCAPD3 | non-SMC condensin II complex, subunit D3 |
|
increases expression | EXP | 11 | 134,022,337 | 134,094,426 | RGD:6480464 | CTD | |
| G | NCOA3 | nuclear receptor coactivator 3 |
|
increases expression | EXP | 20 | 46,130,601 | 46,285,621 | RGD:6480464 | CTD | |
| G | NDUFS2 | NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) |
|
decreases expression | EXP | 1 | 161,169,105 | 161,184,185 | RGD:6480464 | CTD | |
| G | NFATC4 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
|
increases expression | EXP | 14 | 24,836,145 | 24,848,810 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases activity | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions | EXP | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions | ISO | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions | EXP | 14 | 35,870,716 | 35,873,960 | RGD:6480464 | CTD | |
| G | NGF | nerve growth factor (beta polypeptide) |
|
increases expression | EXP | 1 | 115,828,537 | 115,880,857 | RGD:6480464 | CTD | |
| G | NLRP1 | NLR family, pyrin domain containing 1 |
|
decreases expression | EXP | 17 | 5,404,719 | 5,487,832 | RGD:6480464 | CTD | |
| G | NMT2 | N-myristoyltransferase 2 |
|
increases expression | EXP | 10 | 15,147,771 | 15,210,695 | RGD:6480464 | CTD | |
| G | NOD1 | nucleotide-binding oligomerization domain containing 1 |
|
decreases expression | EXP | 7 | 30,464,143 | 30,518,393 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases activity | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NR4A1 | nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression | ISO | 12 | 52,416,616 | 52,453,291 | RGD:6480464 | CTD | |
| G | NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 |
|
increases expression | EXP | 15 | 88,419,988 | 88,799,962 | RGD:6480464 | CTD | |
| G | NUP107 | nucleoporin 107kDa |
|
increases expression | EXP | 12 | 69,080,731 | 69,136,473 | RGD:6480464 | CTD | |
| G | OGG1 | 8-oxoguanine DNA glycosylase |
|
decreases expression | ISO | 3 | 9,791,628 | 9,808,353 | RGD:6480464 | CTD | |
| G | OPRD1 | opioid receptor, delta 1 |
|
multiple interactions | ISO | 1 | 29,138,654 | 29,190,208 | RGD:6480464 | CTD | |
| G | OPRK1 | opioid receptor, kappa 1 |
|
multiple interactions | ISO | 8 | 54,138,276 | 54,164,194 | RGD:6480464 | CTD | |
| G | OPRM1 | opioid receptor, mu 1 |
|
multiple interactions | ISO | 6 | 154,331,631 | 154,568,001 | RGD:6480464 | CTD | |
| G | OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin |
|
decreases expression | EXP | 12 | 58,087,738 | 58,115,340 | RGD:6480464 | CTD | |
| G | P2RX2 | purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions | ISO | 12 | 133,195,403 | 133,198,972 | RGD:6480464 | CTD | |
| G | P2RX4 | purinergic receptor P2X, ligand-gated ion channel, 4 |
|
multiple interactions | ISO | 12 | 121,647,664 | 121,671,909 | RGD:6480464 | CTD | |
| G | P2RX4 | purinergic receptor P2X, ligand-gated ion channel, 4 |
|
multiple interactions | ISO | 12 | 121,647,664 | 121,671,909 | RGD:6480464 | CTD | |
| G | P2RX4 | purinergic receptor P2X, ligand-gated ion channel, 4 |
|
multiple interactions | ISO | 12 | 121,647,664 | 121,671,909 | RGD:6480464 | CTD | |
| G | PARK7 | parkinson protein 7 |
|
increases expression | EXP | 1 | 8,021,714 | 8,045,342 | RGD:6480464 | CTD | |
| G | PCDHB4 | protocadherin beta 4 |
|
decreases expression | ISO | 5 | 140,501,581 | 140,505,201 | RGD:6480464 | CTD | |
| G | PDE1A | phosphodiesterase 1A, calmodulin-dependent |
|
decreases expression | ISO | 2 | 183,004,762 | 183,387,572 | RGD:6480464 | CTD | |
| G | PDE4DIP | phosphodiesterase 4D interacting protein |
|
increases expression | EXP | 1 | 144,851,424 | 145,076,186 | RGD:6480464 | CTD | |
| G | PDIA4 | protein disulfide isomerase family A, member 4 |
|
decreases expression | EXP | 7 | 148,700,154 | 148,725,782 | RGD:6480464 | CTD | |
| G | PDS5B | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
|
decreases expression | EXP | 13 | 33,160,564 | 33,352,158 | RGD:6480464 | CTD | |
| G | PEX14 | peroxisomal biogenesis factor 14 |
|
increases expression | EXP | 1 | 10,535,003 | 10,690,815 | RGD:6480464 | CTD | |
| G | PGC | progastricsin (pepsinogen C) |
|
decreases expression | EXP | 6 | 41,704,449 | 41,715,139 | RGD:6480464 | CTD | |
| G | PHOX2B | paired-like homeobox 2b |
|
increases expression | EXP | 4 | 41,746,099 | 41,750,987 | RGD:6480464 | CTD | |
| G | PIAS4 | protein inhibitor of activated STAT, 4 |
|
decreases expression | ISO | 19 | 4,007,749 | 4,038,067 | RGD:6480464 | CTD | |
| G | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression | ISO | 5 | 67,511,584 | 67,597,649 | RGD:6480464 | CTD | |
| G | PIK3R4 | phosphoinositide-3-kinase, regulatory subunit 4 |
|
increases expression | EXP | 3 | 130,397,778 | 130,465,696 | RGD:6480464 | CTD | |
| G | PIKFYVE | phosphoinositide kinase, FYVE finger containing |
|
decreases expression | EXP | 2 | 209,130,991 | 209,223,475 | RGD:6480464 | CTD | |
| G | PLD1 | phospholipase D1, phosphatidylcholine-specific |
|
increases phosphorylation | ISO | 3 | 171,318,195 | 171,528,284 | RGD:6480464 | CTD | |
| G | PLGLB1 | plasminogen-like B1 |
|
increases expression | EXP | 2 | 87,237,587 | 87,248,969 | RGD:6480464 | CTD | |
| G | PMCH | pro-melanin-concentrating hormone |
|
decreases expression | EXP | 12 | 102,590,237 | 102,591,614 | RGD:6480464 | CTD | |
| G | PNMA1 | paraneoplastic Ma antigen 1 |
|
decreases expression | EXP | 14 | 74,178,486 | 74,181,128 | RGD:6480464 | CTD | |
| G | POGK | pogo transposable element with KRAB domain |
|
affects expression | EXP | 1 | 166,808,724 | 166,823,709 | RGD:6480464 | CTD | |
| G | POLD2 | polymerase (DNA directed), delta 2, accessory subunit |
|
affects expression | EXP | 7 | 44,154,279 | 44,163,169 | RGD:6480464 | CTD | |
| G | POU2F3 | POU class 2 homeobox 3 |
|
increases expression | EXP | 11 | 120,107,349 | 120,190,653 | RGD:6480464 | CTD | |
| G | PPIA | peptidylprolyl isomerase A (cyclophilin A) |
|
increases expression | EXP | 7 | 44,836,241 | 44,842,716 | RGD:6480464 | CTD | |
| G | PPIH | peptidylprolyl isomerase H (cyclophilin H) |
|
increases expression | EXP | 1 | 43,124,048 | 43,142,429 | RGD:6480464 | CTD | |
| G | PPP1R12A | protein phosphatase 1, regulatory subunit 12A |
|
increases expression | EXP | 12 | 80,167,343 | 80,329,235 | RGD:6480464 | CTD | |
| G | PPP1R15A | protein phosphatase 1, regulatory subunit 15A |
|
decreases expression | EXP | 19 | 49,375,649 | 49,379,319 | RGD:6480464 | CTD | |
| G | PPP3CB | protein phosphatase 3, catalytic subunit, beta isozyme |
|
decreases expression | ISO | 10 | 75,196,563 | 75,255,782 | RGD:6480464 | CTD | |
| G | PPT2 | palmitoyl-protein thioesterase 2 |
|
decreases expression | EXP | 6 | 32,121,229 | 32,131,458 | RGD:6480464 | CTD | |
| G | PRDX2 | peroxiredoxin 2 |
|
increases expression | ISO | 19 | 12,907,634 | 12,912,694 | RGD:6480464 | CTD | |
| G | PRDX6 | peroxiredoxin 6 |
|
decreases expression | EXP | 1 | 173,446,486 | 173,457,946 | RGD:6480464 | CTD | |
| G | PRKCA | protein kinase C, alpha |
|
increases expression | ISO | 17 | 64,298,926 | 64,806,862 | RGD:6480464 | CTD | |
| G | PRKCG | protein kinase C, gamma |
|
increases expression | ISO | 19 | 54,385,467 | 54,410,901 | RGD:6480464 | CTD | |
| G | PSPH | phosphoserine phosphatase |
|
decreases expression | EXP | 7 | 56,078,744 | 56,119,268 | RGD:6480464 | CTD | |
| G | PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53kDa |
|
increases expression | ISO | 14 | 52,781,016 | 52,795,324 | RGD:6480464 | CTD | |
| G | PTTG1 | pituitary tumor-transforming 1 |
|
increases expression | EXP | 5 | 159,848,865 | 159,855,746 | RGD:6480464 | CTD | |
| G | PXDN | peroxidasin homolog (Drosophila) |
|
decreases expression | EXP | 2 | 1,635,659 | 1,748,291 | RGD:6480464 | CTD | |
| G | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
increases expression | EXP | 7 | 6,414,126 | 6,443,598 | RGD:6480464 | CTD | |
| G | RACGAP1 | Rac GTPase activating protein 1 |
|
increases expression | EXP | 12 | 50,382,945 | 50,419,307 | RGD:6480464 | CTD | |
| G | RAD18 | RAD18 homolog (S. cerevisiae) |
|
decreases expression | ISO | 3 | 8,918,880 | 9,005,159 | RGD:6480464 | CTD | |
| G | RALGAPA1 | Ral GTPase activating protein, alpha subunit 1 (catalytic) |
|
decreases expression | EXP | 14 | 36,007,558 | 36,278,432 | RGD:6480464 | CTD | |
| G | RARA | retinoic acid receptor, alpha |
|
decreases expression | ISO | 17 | 38,465,423 | 38,513,895 | RGD:6480464 | CTD | |
| G | RBM12B-AS1 | RBM12B antisense RNA 1 |
|
increases expression | EXP | 8 | 94,752,339 | 94,753,047 | RGD:6480464 | CTD | |
| G | RBPMS | RNA binding protein with multiple splicing |
|
increases expression | EXP | 8 | 30,241,944 | 30,429,734 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | EXP | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RELN | reelin |
|
decreases expression | EXP | 7 | 103,112,231 | 103,629,963 | RGD:6480464 | CTD | |
| G | RHOBTB2 | Rho-related BTB domain containing 2 |
|
increases expression | EXP | 8 | 22,844,930 | 22,877,710 | RGD:6480464 | CTD | |
| G | RNASEH1 | ribonuclease H1 |
|
decreases expression | EXP | 2 | 3,592,678 | 3,605,940 | RGD:6480464 | CTD | |
| G | RNASEH2A | ribonuclease H2, subunit A |
|
decreases expression | EXP | 19 | 12,917,428 | 12,924,462 | RGD:6480464 | CTD | |
| G | RNASEH2A | ribonuclease H2, subunit A |
|
increases expression | EXP | 19 | 12,917,428 | 12,924,462 | RGD:6480464 | CTD | |
| G | RND2 | Rho family GTPase 2 |
|
increases methylation | EXP | 17 | 41,177,258 | 41,184,058 | RGD:6480464 | CTD | |
| G | RNF138 | ring finger protein 138, E3 ubiquitin protein ligase |
|
increases expression | EXP | 18 | 29,671,818 | 29,711,524 | RGD:6480464 | CTD | |
| G | RNF141 | ring finger protein 141 |
|
decreases expression | EXP | 11 | 10,533,225 | 10,562,774 | RGD:6480464 | CTD | |
| G | RNGTT | RNA guanylyltransferase and 5'-phosphatase |
|
affects expression | EXP | 6 | 89,319,989 | 89,673,348 | RGD:6480464 | CTD | |
| G | RPL19 | ribosomal protein L19 |
|
decreases expression | EXP | 17 | 37,356,536 | 37,360,980 | RGD:6480464 | CTD | |
| G | RPL28 | ribosomal protein L28 |
|
decreases expression | EXP | 19 | 55,897,300 | 55,903,453 | RGD:6480464 | CTD | |
| G | RPS5 | ribosomal protein S5 |
|
decreases expression | EXP | 19 | 58,898,636 | 58,906,171 | RGD:6480464 | CTD | |
| G | RRBP1 | ribosome binding protein 1 |
|
decreases expression | EXP | 20 | 17,594,323 | 17,662,928 | RGD:6480464 | CTD | |
| G | RTN4 | reticulon 4 |
|
decreases expression | EXP | 2 | 55,199,325 | 55,277,734 | RGD:6480464 | CTD | |
| G | RTP3 | receptor (chemosensory) transporter protein 3 |
|
decreases expression | ISO | 3 | 46,539,485 | 46,542,439 | RGD:6480464 | CTD | |
| G | SAA1 | serum amyloid A1 |
|
increases expression | ISO | 11 | 18,287,808 | 18,291,524 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
increases expression | EXP | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SAP30 | Sin3A-associated protein, 30kDa |
|
increases expression | EXP | 4 | 174,292,093 | 174,298,683 | RGD:6480464 | CTD | |
| G | SCAF4 | SR-related CTD-associated factor 4 |
|
increases expression | EXP | 21 | 33,043,313 | 33,104,431 | RGD:6480464 | CTD | |
| G | SCARB1 | scavenger receptor class B, member 1 |
|
increases expression | EXP | 12 | 125,262,174 | 125,348,519 | RGD:6480464 | CTD | |
| G | SCG3 | secretogranin III |
|
increases expression | EXP | 15 | 51,973,550 | 52,013,223 | RGD:6480464 | CTD | |
| G | SEC24C | SEC24 family, member C (S. cerevisiae) |
|
increases expression | EXP | 10 | 75,504,131 | 75,531,933 | RGD:6480464 | CTD | |
| G | SENP6 | SUMO1/sentrin specific peptidase 6 |
|
increases expression | EXP | 6 | 76,311,622 | 76,427,997 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
affects abundance | EXP | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SEPP1 | selenoprotein P, plasma, 1 |
|
affects binding | EXP | 5 | 42,799,982 | 42,812,024 | RGD:6480464 | CTD | |
| G | SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
|
affects expression | EXP | 14 | 95,078,714 | 95,090,390 | RGD:6480464 | CTD | |
| G | SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
|
decreases expression | EXP | 6 | 2,832,566 | 2,842,283 | RGD:6480464 | CTD | |
| G | SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 |
|
decreases expression | EXP | 1 | 173,872,942 | 173,886,516 | RGD:6480464 | CTD | |
| G | SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
affects expression | EXP | 11 | 57,365,027 | 57,382,326 | RGD:6480464 | CTD | |
| G | SFRP1 | secreted frizzled-related protein 1 |
|
decreases expression | EXP | 8 | 41,119,476 | 41,166,990 | RGD:6480464 | CTD | |
| G | SH3BP2 | SH3-domain binding protein 2 |
|
increases expression | EXP | 4 | 2,794,750 | 2,842,823 | RGD:6480464 | CTD | |
| G | SH3GLB2 | SH3-domain GRB2-like endophilin B2 |
|
increases expression | EXP | 9 | 131,770,313 | 131,790,579 | RGD:6480464 | CTD | |
| G | SH3PXD2A | SH3 and PX domains 2A |
|
increases expression | EXP | 10 | 105,353,784 | 105,615,164 | RGD:6480464 | CTD | |
| G | SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 |
|
decreases expression | EXP | 1 | 154,934,774 | 154,946,959 | RGD:6480464 | CTD | |
| G | SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
increases expression | EXP | 2 | 219,246,752 | 219,261,617 | RGD:6480464 | CTD | |
| G | SLC12A2 | solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
affects transport | ISO | 5 | 127,419,483 | 127,525,380 | RGD:6480464 | CTD | |
| G | SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 |
|
increases expression | ISO | 6 | 160,542,863 | 160,579,750 | RGD:6480464 | CTD | |
| G | SLC22A6 | solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions | EXP | 11 | 62,744,069 | 62,752,495 | RGD:6480464 | CTD | |
| G | SLC22A6 | solute carrier family 22 (organic anion transporter), member 6 |
|
affects abundance | EXP | 11 | 62,744,069 | 62,752,495 | RGD:6480464 | CTD | |
| G | SLC25A22 | solute carrier family 25 (mitochondrial carrier: glutamate), member 22 |
|
decreases expression | EXP | 11 | 790,475 | 798,269 | RGD:6480464 | CTD | |
| G | SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression | ISO | 17 | 7,185,054 | 7,191,367 | RGD:6480464 | CTD | |
| G | SLC30A1 | solute carrier family 30 (zinc transporter), member 1 |
|
increases expression | ISO | 1 | 211,748,381 | 211,752,099 | RGD:6480464 | CTD | |
| G | SLC39A8 | solute carrier family 39 (zinc transporter), member 8 |
|
multiple interactions | ISO | 4 | 103,172,198 | 103,266,655 | RGD:6480464 | CTD | |
| G | SLC6A4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
affects response to substance | EXP | 17 | 28,523,376 | 28,562,954 | RGD:6480464 | CTD | |
| G | SLC7A2 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
|
decreases expression | EXP | 8 | 17,354,597 | 17,428,077 | RGD:6480464 | CTD | |
| G | SLC7A5 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
affects abundance | EXP | 16 | 87,863,629 | 87,903,100 | RGD:6480464 | CTD | |
| G | SLC9A3R2 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
|
increases expression | EXP | 16 | 2,076,869 | 2,089,027 | RGD:6480464 | CTD | |
| G | SLIT3 | slit homolog 3 (Drosophila) |
|
decreases expression | EXP | 5 | 168,093,071 | 168,728,133 | RGD:6480464 | CTD | |
| G | SMAD2 | SMAD family member 2 |
|
increases expression | EXP | 18 | 45,359,466 | 45,457,517 | RGD:6480464 | CTD | |
| G | SMC4 | structural maintenance of chromosomes 4 |
|
increases expression | EXP | 3 | 160,117,430 | 160,152,741 | RGD:6480464 | CTD | |
| G | SMIM14 | small integral membrane protein 14 |
|
increases expression | EXP | 4 | 39,552,550 | 39,640,481 | RGD:6480464 | CTD | |
| G | SNRPA | small nuclear ribonucleoprotein polypeptide A |
|
increases expression | EXP | 19 | 41,256,759 | 41,271,297 | RGD:6480464 | CTD | |
| G | SOX18 | SRY (sex determining region Y)-box 18 |
|
increases expression | EXP | 20 | 62,679,079 | 62,680,979 | RGD:6480464 | CTD | |
| G | SPINK1 | serine peptidase inhibitor, Kazal type 1 |
|
decreases expression | ISO | 5 | 147,204,143 | 147,211,260 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
increases expression | EXP | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SPTBN1 | spectrin, beta, non-erythrocytic 1 |
|
increases expression | EXP | 2 | 54,683,454 | 54,898,583 | RGD:6480464 | CTD | |
| G | SRF | serum response factor (c-fos serum response element-binding transcription factor) |
|
decreases expression | EXP | 6 | 43,138,920 | 43,149,244 | RGD:6480464 | CTD | |
| G | SRSF2 | serine/arginine-rich splicing factor 2 |
|
increases expression | EXP | 17 | 74,730,197 | 74,733,493 | RGD:6480464 | CTD | |
| G | SRSF7 | serine/arginine-rich splicing factor 7 |
|
increases expression | EXP | 2 | 38,970,741 | 38,978,636 | RGD:6480464 | CTD | |
| G | SSBP1 | single-stranded DNA binding protein 1, mitochondrial |
|
increases expression | EXP | 7 | 141,438,121 | 141,450,288 | RGD:6480464 | CTD | |
| G | SSR2 | signal sequence receptor, beta (translocon-associated protein beta) |
|
decreases expression | EXP | 1 | 155,978,839 | 155,990,758 | RGD:6480464 | CTD | |
| G | SSTR3 | somatostatin receptor 3 |
|
decreases expression | EXP | 22 | 37,602,245 | 37,608,353 | RGD:6480464 | CTD | |
| G | STUB1 | STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
decreases expression | EXP | 16 | 730,115 | 732,768 | RGD:6480464 | CTD | |
| G | SUB1 | SUB1 homolog (S. cerevisiae) |
|
decreases expression | EXP | 5 | 32,585,605 | 32,604,185 | RGD:6480464 | CTD | |
| G | SZRD1 | SUZ RNA binding domain containing 1 |
|
affects expression | EXP | 1 | 16,693,583 | 16,724,640 | RGD:6480464 | CTD | |
| G | TAC1 | tachykinin, precursor 1 |
|
increases expression | EXP | 7 | 97,361,271 | 97,369,784 | RGD:6480464 | CTD | |
| G | TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
decreases expression | ISO | 6 | 32,812,986 | 32,821,748 | RGD:6480464 | CTD | |
| G | TAT | tyrosine aminotransferase |
|
multiple interactions | ISO | 16 | 71,600,754 | 71,610,998 | RGD:6480464 | CTD | |
| G | TAT | tyrosine aminotransferase |
|
increases activity | ISO | 16 | 71,600,754 | 71,610,998 | RGD:6480464 | CTD | |
| G | TCF3 | transcription factor 3 |
|
decreases expression | EXP | 19 | 1,609,289 | 1,652,328 | RGD:6480464 | CTD | |
| G | TES | testis derived transcript (3 LIM domains) |
|
decreases expression | ISO | 7 | 115,850,547 | 115,898,837 | RGD:6480464 | CTD | |
| G | TF | transferrin |
|
increases secretion | EXP | 3 | 133,464,977 | 133,497,850 | RGD:6480464 | CTD | |
| G | TGFB2 | transforming growth factor, beta 2 |
|
increases expression | EXP | 1 | 218,518,676 | 218,617,961 | RGD:6480464 | CTD | |
| G | THUMPD3 | THUMP domain containing 3 |
|
decreases expression | ISO | 3 | 9,404,717 | 9,428,475 | RGD:6480464 | CTD | |
| G | TIMM13 | translocase of inner mitochondrial membrane 13 homolog (yeast) |
|
decreases expression | ISO | 19 | 2,425,622 | 2,427,875 | RGD:6480464 | CTD | |
| G | TIMM23 | translocase of inner mitochondrial membrane 23 homolog (yeast) |
|
increases expression | ISO | 10 | 51,592,080 | 51,623,386 | RGD:6480464 | CTD | |
| G | TK2 | thymidine kinase 2, mitochondrial |
|
affects expression | EXP | 16 | 66,541,906 | 66,584,315 | RGD:6480464 | CTD | |
| G | TM2D1 | TM2 domain containing 1 |
|
increases expression | EXP | 1 | 62,146,719 | 62,191,095 | RGD:6480464 | CTD | |
| G | TMF1 | TATA element modulatory factor 1 |
|
decreases expression | EXP | 3 | 69,068,978 | 69,101,484 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
affects expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
|
increases expression | EXP | 6 | 138,188,325 | 138,204,451 | RGD:6480464 | CTD | |
| G | TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 |
|
increases expression | EXP | 5 | 118,604,418 | 118,730,294 | RGD:6480464 | CTD | |
| G | TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 |
|
decreases expression | ISO | 5 | 118,604,418 | 118,730,294 | RGD:6480464 | CTD | |
| G | TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A |
|
increases expression | ISO | 12 | 6,437,923 | 6,451,283 | RGD:6480464 | CTD | |
| G | TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression | EXP | 3 | 172,223,298 | 172,241,297 | RGD:6480464 | CTD | |
| G | TOX3 | TOX high mobility group box family member 3 |
|
increases expression | EXP | 16 | 52,471,918 | 52,581,714 | RGD:6480464 | CTD | |
| G | TPM2 | tropomyosin 2 (beta) |
|
increases expression | EXP | 9 | 35,681,990 | 35,690,053 | RGD:6480464 | CTD | |
| G | TRADD | TNFRSF1A-associated via death domain |
|
increases expression | ISO | 16 | 67,188,088 | 67,193,812 | RGD:6480464 | CTD | |
| G | TRIB3 | tribbles homolog 3 (Drosophila) |
|
decreases expression | EXP | 20 | 361,308 | 378,203 | RGD:6480464 | CTD | |
| G | TRIP13 | thyroid hormone receptor interactor 13 |
|
increases expression | EXP | 5 | 892,969 | 918,164 | RGD:6480464 | CTD | |
| G | TSPAN7 | tetraspanin 7 |
|
decreases expression | EXP | X | 38,420,731 | 38,548,172 | RGD:6480464 | CTD | |
| G | TST | thiosulfate sulfurtransferase (rhodanese) |
|
decreases expression | EXP | 22 | 37,406,900 | 37,416,224 | RGD:6480464 | CTD | |
| G | TWF2 | twinfilin actin-binding protein 2 |
|
decreases expression | EXP | 3 | 52,262,626 | 52,273,183 | RGD:6480464 | CTD | |
| G | TXN | thioredoxin |
|
affects binding | EXP | 9 | 113,006,092 | 113,018,920 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases expression | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD2 | thioredoxin reductase 2 |
|
decreases activity | ISO | 22 | 19,863,040 | 19,929,359 | RGD:6480464 | CTD | |
| G | TYMS | thymidylate synthetase |
|
increases expression | EXP | 18 | 657,604 | 673,499 | RGD:6480464 | CTD | |
| G | UBE2C | ubiquitin-conjugating enzyme E2C |
|
increases expression | EXP | 20 | 44,441,255 | 44,445,596 | RGD:6480464 | CTD | |
| G | UBE2N | ubiquitin-conjugating enzyme E2N |
|
decreases expression | EXP | 12 | 93,802,088 | 93,836,026 | RGD:6480464 | CTD | |
| G | UGCG | UDP-glucose ceramide glucosyltransferase |
|
increases expression | EXP | 9 | 114,659,206 | 114,695,439 | RGD:6480464 | CTD | |
| G | UQCRB | ubiquinol-cytochrome c reductase binding protein |
|
increases expression | EXP | 8 | 97,238,904 | 97,247,862 | RGD:6480464 | CTD | |
| G | UROD | uroporphyrinogen decarboxylase |
|
decreases activity | EXP | 1 | 45,477,805 | 45,481,341 | RGD:6480464 | CTD | |
| G | USP39 | ubiquitin specific peptidase 39 |
|
increases expression | EXP | 2 | 85,829,965 | 85,876,407 | RGD:6480464 | CTD | |
| G | USPL1 | ubiquitin specific peptidase like 1 |
|
increases expression | EXP | 13 | 31,191,830 | 31,233,686 | RGD:6480464 | CTD | |
| G | VTN | vitronectin |
|
decreases expression | EXP | 17 | 26,694,298 | 26,697,373 | RGD:6480464 | CTD | |
| G | VWA1 | von Willebrand factor A domain containing 1 |
|
increases expression | EXP | 1 | 1,370,903 | 1,378,262 | RGD:6480464 | CTD | |
| G | WDR12 | WD repeat domain 12 |
|
decreases expression | ISO | 2 | 203,745,323 | 203,776,949 | RGD:6480464 | CTD | |
| G | WIPI1 | WD repeat domain, phosphoinositide interacting 1 |
|
decreases expression | ISO | 17 | 66,417,422 | 66,453,653 | RGD:6480464 | CTD | |
| G | XIST | X inactive specific transcript (non-protein coding) |
|
increases expression | ISO | X | 73,040,486 | 73,072,588 | RGD:6480464 | CTD | |
| G | YBX1 | Y box binding protein 1 |
|
increases expression | EXP | 1 | 43,148,066 | 43,168,020 | RGD:6480464 | CTD | |
| G | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
decreases expression | EXP | 8 | 101,930,804 | 101,965,623 | RGD:6480464 | CTD | |
| G | ZBTB1 | zinc finger and BTB domain containing 1 |
|
increases expression | EXP | 14 | 64,971,292 | 65,000,408 | RGD:6480464 | CTD | |
| G | ZBTB10 | zinc finger and BTB domain containing 10 |
|
increases expression | EXP | 8 | 81,398,448 | 81,434,610 | RGD:6480464 | CTD | |
| G | ZBTB16 | zinc finger and BTB domain containing 16 |
|
increases expression | EXP | 11 | 113,930,431 | 114,121,398 | RGD:6480464 | CTD | |
| G | ZBTB38 | zinc finger and BTB domain containing 38 |
|
increases expression | EXP | 3 | 141,043,055 | 141,168,634 | RGD:6480464 | CTD | |
| G | ZNF10 | zinc finger protein 10 |
|
decreases expression | EXP | 12 | 133,707,214 | 133,736,051 | RGD:6480464 | CTD | |
| G | ZNF174 | zinc finger protein 174 |
|
decreases expression | EXP | 16 | 3,451,190 | 3,459,364 | RGD:6480464 | CTD | |
| G | ZNF254 | zinc finger protein 254 |
|
decreases expression | EXP | 19 | 24,269,976 | 24,312,654 | RGD:6480464 | CTD | |
| G | ZNF80 | zinc finger protein 80 |
|
increases expression | EXP | 3 | 113,953,478 | 113,956,425 | RGD:6480464 | CTD | |
| G | ZWINT | ZW10 interactor, kinetochore protein |
|
increases expression | EXP | 10 | 58,117,199 | 58,121,034 | RGD:6480464 | CTD | |
methylmercury chloride
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases expression | ISO | 9 | 133,589,268 | 133,763,062 | RGD:6480464 | CTD | |
| G | ABR | active BCR-related |
|
affects expression | ISO | 17 | 906,758 | 1,090,616 | RGD:6480464 | CTD | |
| G | ADARB1 | adenosine deaminase, RNA-specific, B1 |
|
decreases expression | ISO | 21 | 46,494,493 | 46,646,478 | RGD:6480464 | CTD | |
| G | AGRN | agrin |
|
affects expression | ISO | 1 | 955,503 | 991,499 | RGD:6480464 | CTD | |
| G | AKR1C3 | aldo-keto reductase family 1, member C3 |
|
increases expression | ISO | 10 | 5,090,958 | 5,149,878 | RGD:6480464 | CTD | |
| G | AKTIP | AKT interacting protein |
|
decreases expression | ISO | 16 | 53,525,192 | 53,537,170 | RGD:6480464 | CTD | |
| G | ALB | albumin |
|
multiple interactions | EXP | 4 | 74,269,972 | 74,287,129 | RGD:6480464 | CTD | |
| G | ALCAM | activated leukocyte cell adhesion molecule |
|
affects expression | ISO | 3 | 105,085,557 | 105,295,757 | RGD:6480464 | CTD | |
| G | ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 |
|
increases expression | ISO | 1 | 165,631,449 | 165,667,900 | RGD:6480464 | CTD | |
| G | ANKRD37 | ankyrin repeat domain 37 |
|
decreases expression | ISO | 4 | 186,317,840 | 186,321,390 | RGD:6480464 | CTD | |
| G | ARC | activity-regulated cytoskeleton-associated protein |
|
increases expression | ISO | 8 | 143,692,405 | 143,695,833 | RGD:6480464 | CTD | |
| G | ARG2 | arginase, type II |
|
increases expression | ISO | 14 | 68,086,579 | 68,118,437 | RGD:6480464 | CTD | |
| G | ARIH2 | ariadne homolog 2 (Drosophila) |
|
increases expression | ISO | 3 | 48,956,281 | 49,022,974 | RGD:6480464 | CTD | |
| G | ARRB2 | arrestin, beta 2 |
|
increases expression | ISO | 17 | 4,613,789 | 4,624,795 | RGD:6480464 | CTD | |
| G | ASPM | asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
decreases expression | ISO | 1 | 197,053,257 | 197,115,824 | RGD:6480464 | CTD | |
| G | ASPM | asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
affects expression | ISO | 1 | 197,053,257 | 197,115,824 | RGD:6480464 | CTD | |
| G | ATF2 | activating transcription factor 2 |
|
increases expression | ISO | 2 | 175,936,978 | 176,032,934 | RGD:6480464 | CTD | |
| G | ATF3 | activating transcription factor 3 |
|
increases expression | ISO | 1 | 212,738,676 | 212,794,119 | RGD:6480464 | CTD | |
| G | ATPAF1 | ATP synthase mitochondrial F1 complex assembly factor 1 |
|
decreases expression | ISO | 1 | 47,100,711 | 47,134,099 | RGD:6480464 | CTD | |
| G | BIRC5 | baculoviral IAP repeat containing 5 |
|
decreases expression | ISO | 17 | 76,210,277 | 76,221,716 | RGD:6480464 | CTD | |
| G | BOC | BOC cell adhesion associated, oncogene regulated |
|
affects expression | ISO | 3 | 112,931,375 | 113,006,306 | RGD:6480464 | CTD | |
| G | BOC | BOC cell adhesion associated, oncogene regulated |
|
affects expression | ISO | 3 | 112,931,375 | 113,006,306 | RGD:6480464 | CTD | |
| G | BTRC | beta-transducin repeat containing E3 ubiquitin protein ligase |
|
decreases expression | ISO | 10 | 103,113,790 | 103,317,078 | RGD:6480464 | CTD | |
| G | C2CD5 | C2 calcium-dependent domain containing 5 |
|
increases expression | ISO | 12 | 22,601,517 | 22,697,452 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
increases activity | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases expression | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
decreases activity | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CBLC | Cbl proto-oncogene, E3 ubiquitin protein ligase C |
|
decreases expression | ISO | 19 | 45,281,126 | 45,303,903 | RGD:6480464 | CTD | |
| G | CCDC174 | coiled-coil domain containing 174 |
|
decreases expression | ISO | 3 | 14,693,253 | 14,714,166 | RGD:6480464 | CTD | |
| G | CCNA2 | cyclin A2 |
|
decreases expression | ISO | 4 | 122,737,599 | 122,745,088 | RGD:6480464 | CTD | |
| G | CCNB1 | cyclin B1 |
|
decreases expression | ISO | 5 | 68,462,837 | 68,474,072 | RGD:6480464 | CTD | |
| G | CCNB1IP1 | cyclin B1 interacting protein 1, E3 ubiquitin protein ligase |
|
affects expression | ISO | 14 | 20,779,527 | 20,801,471 | RGD:6480464 | CTD | |
| G | CCNB2 | cyclin B2 |
|
decreases expression | ISO | 15 | 59,397,284 | 59,417,244 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
decreases expression | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND3 | cyclin D3 |
|
decreases expression | ISO | 6 | 41,902,671 | 42,016,610 | RGD:6480464 | CTD | |
| G | CCND3 | cyclin D3 |
|
decreases expression | ISO | 6 | 41,902,671 | 42,016,610 | RGD:6480464 | CTD | |
| G | CCNE1 | cyclin E1 |
|
increases cleavage | ISO | 19 | 30,302,901 | 30,315,215 | RGD:6480464 | CTD | |
| G | CCNE1 | cyclin E1 |
|
decreases expression | ISO | 19 | 30,302,901 | 30,315,215 | RGD:6480464 | CTD | |
| G | CCNE2 | cyclin E2 |
|
decreases expression | ISO | 8 | 95,892,452 | 95,907,482 | RGD:6480464 | CTD | |
| G | CCNT1 | cyclin T1 |
|
decreases expression | ISO | 12 | 49,082,241 | 49,110,781 | RGD:6480464 | CTD | |
| G | CCZ1 | CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae) |
|
decreases expression | ISO | 7 | 5,938,341 | 5,965,605 | RGD:6480464 | CTD | |
| G | CCZ1 | CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae) |
|
decreases expression | ISO | 7 | 5,938,341 | 5,965,605 | RGD:6480464 | CTD | |
| G | CD200R1L | CD200 receptor 1-like |
|
increases expression | ISO | 3 | 112,534,556 | 112,564,797 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CDC20 | cell division cycle 20 |
|
decreases expression | ISO | 1 | 43,824,626 | 43,828,874 | RGD:6480464 | CTD | |
| G | CDC25B | cell division cycle 25B |
|
increases expression | ISO | 20 | 3,776,401 | 3,786,762 | RGD:6480464 | CTD | |
| G | CDC25B | cell division cycle 25B |
|
decreases expression | ISO | 20 | 3,776,401 | 3,786,762 | RGD:6480464 | CTD | |
| G | CDC25C | cell division cycle 25C |
|
decreases expression | ISO | 5 | 137,620,959 | 137,667,516 | RGD:6480464 | CTD | |
| G | CDC42 | cell division cycle 42 |
|
decreases expression | ISO | 1 | 22,379,120 | 22,419,436 | RGD:6480464 | CTD | |
| G | CDCA3 | cell division cycle associated 3 |
|
decreases expression | ISO | 12 | 6,957,972 | 6,960,456 | RGD:6480464 | CTD | |
| G | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) |
|
affects expression | ISO | 16 | 68,771,195 | 68,869,444 | RGD:6480464 | CTD | |
| G | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) |
|
increases expression | ISO | 16 | 68,771,195 | 68,869,444 | RGD:6480464 | CTD | |
| G | CDK1 | cyclin-dependent kinase 1 |
|
decreases expression | ISO | 10 | 62,538,089 | 62,554,610 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
decreases expression | ISO | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
decreases methylation | ISO | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
decreases expression | ISO | 1 | 51,434,367 | 51,440,309 | RGD:6480464 | CTD | |
| G | CDKN3 | cyclin-dependent kinase inhibitor 3 |
|
decreases expression | ISO | 14 | 54,863,673 | 54,886,936 | RGD:6480464 | CTD | |
| G | CDX2 | caudal type homeobox 2 |
|
affects expression | ISO | 13 | 28,536,205 | 28,543,505 | RGD:6480464 | CTD | |
| G | CELSR1 | cadherin, EGF LAG seven-pass G-type receptor 1 |
|
affects expression | ISO | 22 | 46,756,731 | 46,933,067 | RGD:6480464 | CTD | |
| G | CENPP | centromere protein P |
|
decreases expression | ISO | 9 | 95,087,741 | 95,377,446 | RGD:6480464 | CTD | |
| G | CETN3 | centrin, EF-hand protein, 3 |
|
decreases expression | ISO | 5 | 89,689,528 | 89,705,603 | RGD:6480464 | CTD | |
| G | CHD7 | chromodomain helicase DNA binding protein 7 |
|
affects expression | ISO | 8 | 61,591,324 | 61,780,587 | RGD:6480464 | CTD | |
| G | CHEK1 | checkpoint kinase 1 |
|
decreases expression | ISO | 11 | 125,495,031 | 125,546,150 | RGD:6480464 | CTD | |
| G | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
|
decreases expression | ISO | 8 | 27,317,278 | 27,336,813 | RGD:6480464 | CTD | |
| G | CHRNA6 | cholinergic receptor, nicotinic, alpha 6 (neuronal) |
|
decreases expression | ISO | 8 | 42,607,763 | 42,623,929 | RGD:6480464 | CTD | |
| G | CHRNB3 | cholinergic receptor, nicotinic, beta 3 (neuronal) |
|
decreases expression | ISO | 8 | 42,552,562 | 42,592,209 | RGD:6480464 | CTD | |
| G | CHRNE | cholinergic receptor, nicotinic, epsilon (muscle) |
|
increases expression | ISO | 17 | 4,801,064 | 4,806,369 | RGD:6480464 | CTD | |
| G | CHRNG | cholinergic receptor, nicotinic, gamma (muscle) |
|
decreases expression | ISO | 2 | 233,404,437 | 233,411,038 | RGD:6480464 | CTD | |
| G | COCH | coagulation factor C homolog, cochlin (Limulus polyphemus) |
|
decreases expression | ISO | 14 | 31,343,741 | 31,359,822 | RGD:6480464 | CTD | |
| G | COCH | coagulation factor C homolog, cochlin (Limulus polyphemus) |
|
decreases expression | ISO | 14 | 31,343,741 | 31,359,822 | RGD:6480464 | CTD | |
| G | CREBBP | CREB binding protein |
|
affects expression | ISO | 16 | 3,775,055 | 3,930,121 | RGD:6480464 | CTD | |
| G | CSNK2A2 | casein kinase 2, alpha prime polypeptide |
|
decreases expression | ISO | 16 | 58,191,811 | 58,231,782 | RGD:6480464 | CTD | |
| G | CXCL12 | chemokine (C-X-C motif) ligand 12 |
|
affects expression | ISO | 10 | 44,865,605 | 44,880,545 | RGD:6480464 | CTD | |
| G | CYB5R3 | cytochrome b5 reductase 3 |
|
decreases expression | ISO | 22 | 43,013,846 | 43,045,405 | RGD:6480464 | CTD | |
| G | CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 |
|
affects expression | ISO | 10 | 94,833,232 | 94,837,641 | RGD:6480464 | CTD | |
| G | CYP7B1 | cytochrome P450, family 7, subfamily B, polypeptide 1 |
|
decreases expression | ISO | 8 | 65,508,529 | 65,711,348 | RGD:6480464 | CTD | |
| G | DCAF11 | DDB1 and CUL4 associated factor 11 |
|
decreases expression | ISO | 14 | 24,583,906 | 24,594,451 | RGD:6480464 | CTD | |
| G | DDHD1 | DDHD domain containing 1 |
|
increases expression | ISO | 14 | 53,503,458 | 53,620,046 | RGD:6480464 | CTD | |
| G | DDR1 | discoidin domain receptor tyrosine kinase 1 |
|
affects expression | ISO | 6 | 30,851,861 | 30,867,933 | RGD:6480464 | CTD | |
| G | DDX31 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 |
|
decreases expression | ISO | 9 | 135,469,676 | 135,545,788 | RGD:6480464 | CTD | |
| G | DDX60 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
|
decreases expression | ISO | 4 | 169,137,442 | 169,239,958 | RGD:6480464 | CTD | |
| G | DLC1 | deleted in liver cancer 1 |
|
affects expression | ISO | 8 | 12,940,872 | 13,372,429 | RGD:6480464 | CTD | |
| G | DLL1 | delta-like 1 (Drosophila) |
|
affects expression | ISO | 6 | 170,591,294 | 170,599,697 | RGD:6480464 | CTD | |
| G | DLL3 | delta-like 3 (Drosophila) |
|
affects expression | ISO | 19 | 39,989,557 | 39,999,121 | RGD:6480464 | CTD | |
| G | DMPK | dystrophia myotonica-protein kinase |
|
decreases response to substance | ISO | 19 | 46,272,975 | 46,285,815 | RGD:6480464 | CTD | |
| G | DMPK | dystrophia myotonica-protein kinase |
|
decreases response to substance | ISO | 19 | 46,272,975 | 46,285,815 | RGD:6480464 | CTD | |
| G | DNMT1 | DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression | ISO | 19 | 10,244,022 | 10,305,755 | RGD:6480464 | CTD | |
| G | DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression | ISO | 20 | 31,350,191 | 31,397,162 | RGD:6480464 | CTD | |
| G | DNMT3L | DNA (cytosine-5-)-methyltransferase 3-like |
|
affects expression | ISO | 21 | 45,666,222 | 45,682,099 | RGD:6480464 | CTD | |
| G | DPYSL4 | dihydropyrimidinase-like 4 |
|
affects expression | ISO | 10 | 134,000,414 | 134,019,280 | RGD:6480464 | CTD | |
| G | DRD1 | dopamine receptor D1 |
|
decreases expression | ISO | 5 | 174,867,675 | 174,871,163 | RGD:6480464 | CTD | |
| G | DRD2 | dopamine receptor D2 |
|
decreases expression | ISO | 11 | 113,280,317 | 113,346,001 | RGD:6480464 | CTD | |
| G | DRD3 | dopamine receptor D3 |
|
decreases expression | ISO | 3 | 113,847,557 | 113,897,899 | RGD:6480464 | CTD | |
| G | DSG1 | desmoglein 1 |
|
decreases expression | ISO | 18 | 28,898,052 | 28,937,394 | RGD:6480464 | CTD | |
| G | DTX4 | deltex homolog 4 (Drosophila) |
|
decreases expression | ISO | 11 | 58,939,812 | 58,976,060 | RGD:6480464 | CTD | |
| G | DYNC2H1 | dynein, cytoplasmic 2, heavy chain 1 |
|
affects expression | ISO | 11 | 102,980,160 | 103,350,591 | RGD:6480464 | CTD | |
| G | EBPL | emopamil binding protein-like |
|
decreases expression | ISO | 13 | 50,234,810 | 50,265,623 | RGD:6480464 | CTD | |
| G | ECI1 | enoyl-CoA delta isomerase 1 |
|
decreases expression | ISO | 16 | 2,289,873 | 2,301,602 | RGD:6480464 | CTD | |
| G | EFNB3 | ephrin-B3 |
|
affects expression | ISO | 17 | 7,608,520 | 7,614,693 | RGD:6480464 | CTD | |
| G | ELL | elongation factor RNA polymerase II |
|
decreases expression | ISO | 19 | 18,553,473 | 18,632,937 | RGD:6480464 | CTD | |
| G | EMC6 | ER membrane protein complex subunit 6 |
|
decreases expression | ISO | 17 | 3,572,090 | 3,572,962 | RGD:6480464 | CTD | |
| G | EMX2 | empty spiracles homeobox 2 |
|
decreases expression | EXP | 10 | 119,301,956 | 119,309,057 | RGD:6480464 | CTD | |
| G | EMX2 | empty spiracles homeobox 2 |
|
decreases expression | ISO | 10 | 119,301,956 | 119,309,057 | RGD:6480464 | CTD | |
| G | ENDOD1 | endonuclease domain containing 1 |
|
decreases expression | ISO | 11 | 94,822,974 | 94,865,815 | RGD:6480464 | CTD | |
| G | EPHA2 | EPH receptor A2 |
|
affects expression | ISO | 1 | 16,450,832 | 16,482,582 | RGD:6480464 | CTD | |
| G | ESRRB | estrogen-related receptor beta |
|
affects expression | ISO | 14 | 76,837,690 | 76,968,180 | RGD:6480464 | CTD | |
| G | ESYT2 | extended synaptotagmin-like protein 2 |
|
decreases expression | ISO | 7 | 158,523,689 | 158,622,319 | RGD:6480464 | CTD | |
| G | ETV4 | ets variant 4 |
|
affects expression | ISO | 17 | 41,605,211 | 41,623,800 | RGD:6480464 | CTD | |
| G | FABP7 | fatty acid binding protein 7, brain |
|
affects expression | ISO | 6 | 123,100,646 | 123,105,219 | RGD:6480464 | CTD | |
| G | FASTKD3 | FAST kinase domains 3 |
|
decreases expression | ISO | 5 | 7,859,272 | 7,869,150 | RGD:6480464 | CTD | |
| G | FBLN2 | fibulin 2 |
|
increases expression | ISO | 3 | 13,590,625 | 13,679,922 | RGD:6480464 | CTD | |
| G | FBRS | fibrosin |
|
increases expression | ISO | 16 | 30,675,778 | 30,682,131 | RGD:6480464 | CTD | |
| G | FDX1 | ferredoxin 1 |
|
decreases expression | ISO | 11 | 110,300,661 | 110,335,608 | RGD:6480464 | CTD | |
| G | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) |
|
affects expression | ISO | 11 | 125,315,641 | 125,366,206 | RGD:6480464 | CTD | |
| G | FEZF2 | FEZ family zinc finger 2 |
|
affects expression | ISO | 3 | 62,355,347 | 62,359,190 | RGD:6480464 | CTD | |
| G | FGF18 | fibroblast growth factor 18 |
|
affects expression | ISO | 5 | 170,846,667 | 170,884,630 | RGD:6480464 | CTD | |
| G | FGF8 | fibroblast growth factor 8 (androgen-induced) |
|
decreases expression | ISO | 10 | 103,529,887 | 103,540,126 | RGD:6480464 | CTD | |
| G | FGF8 | fibroblast growth factor 8 (androgen-induced) |
|
affects expression | ISO | 10 | 103,529,887 | 103,540,126 | RGD:6480464 | CTD | |
| G | FGFR1 | fibroblast growth factor receptor 1 |
|
affects expression | ISO | 8 | 38,268,656 | 38,326,352 | RGD:6480464 | CTD | |
| G | FHL1 | four and a half LIM domains 1 |
|
increases expression | ISO | X | 135,228,861 | 135,293,518 | RGD:6480464 | CTD | |
| G | FILIP1L | filamin A interacting protein 1-like |
|
increases expression | ISO | 3 | 99,551,988 | 99,833,349 | RGD:6480464 | CTD | |
| G | FLG2 | filaggrin family member 2 |
|
decreases expression | ISO | 1 | 152,321,213 | 152,332,482 | RGD:6480464 | CTD | |
| G | FN1 | fibronectin 1 |
|
affects expression | ISO | 2 | 216,225,177 | 216,300,791 | RGD:6480464 | CTD | |
| G | FOS | FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression | ISO | 14 | 75,745,481 | 75,748,937 | RGD:6480464 | CTD | |
| G | FOS | FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression | ISO | 14 | 75,745,481 | 75,748,937 | RGD:6480464 | CTD | |
| G | FOSL1 | FOS-like antigen 1 |
|
increases expression | ISO | 11 | 65,659,692 | 65,667,997 | RGD:6480464 | CTD | |
| G | FUK | fucokinase |
|
increases expression | ISO | 16 | 70,488,498 | 70,514,177 | RGD:6480464 | CTD | |
| G | GAB1 | GRB2-associated binding protein 1 |
|
affects expression | ISO | 4 | 144,257,983 | 144,395,718 | RGD:6480464 | CTD | |
| G | GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
decreases expression | ISO | 5 | 161,274,197 | 161,326,965 | RGD:6480464 | CTD | |
| G | GABRA4 | gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
|
decreases expression | ISO | 4 | 46,920,917 | 46,996,424 | RGD:6480464 | CTD | |
| G | GABRD | gamma-aminobutyric acid (GABA) A receptor, delta |
|
decreases expression | ISO | 1 | 1,950,768 | 1,962,192 | RGD:6480464 | CTD | |
| G | GABRQ | gamma-aminobutyric acid (GABA) A receptor, theta |
|
decreases expression | ISO | X | 151,806,637 | 151,821,825 | RGD:6480464 | CTD | |
| G | GAD1 | glutamate decarboxylase 1 (brain, 67kDa) |
|
decreases expression | ISO | 2 | 171,673,200 | 171,717,661 | RGD:6480464 | CTD | |
| G | GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
|
decreases expression | ISO | 10 | 26,505,236 | 26,593,491 | RGD:6480464 | CTD | |
| G | GADD45A | growth arrest and DNA-damage-inducible, alpha |
|
increases expression | ISO | 1 | 68,150,860 | 68,154,021 | RGD:6480464 | CTD | |
| G | GADD45A | growth arrest and DNA-damage-inducible, alpha |
|
affects expression | ISO | 1 | 68,150,860 | 68,154,021 | RGD:6480464 | CTD | |
| G | GADD45B | growth arrest and DNA-damage-inducible, beta |
|
increases expression | ISO | 19 | 2,476,123 | 2,478,257 | RGD:6480464 | CTD | |
| G | GALR2 | galanin receptor 2 |
|
increases expression | ISO | 17 | 74,070,892 | 74,073,573 | RGD:6480464 | CTD | |
| G | GALR3 | galanin receptor 3 |
|
decreases expression | ISO | 22 | 38,219,389 | 38,221,502 | RGD:6480464 | CTD | |
| G | GCLC | glutamate-cysteine ligase, catalytic subunit |
|
increases expression | ISO | 6 | 53,362,139 | 53,409,927 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
increases expression | ISO | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GDF10 | growth differentiation factor 10 |
|
decreases expression | ISO | 10 | 48,425,785 | 48,439,138 | RGD:6480464 | CTD | |
| G | GDNF | glial cell derived neurotrophic factor |
|
decreases expression | ISO | 5 | 37,812,779 | 37,839,782 | RGD:6480464 | CTD | |
| G | GJB5 | gap junction protein, beta 5, 31.1kDa |
|
affects expression | ISO | 1 | 35,220,721 | 35,224,112 | RGD:6480464 | CTD | |
| G | GLRA3 | glycine receptor, alpha 3 |
|
decreases expression | ISO | 4 | 175,563,198 | 175,750,465 | RGD:6480464 | CTD | |
| G | GNRH1 | gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
multiple interactions | ISO | 8 | 25,276,774 | 25,282,556 | RGD:6480464 | CTD | |
| G | GNRH1 | gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects secretion | ISO | 8 | 25,276,774 | 25,282,556 | RGD:6480464 | CTD | |
| G | GOSR1 | golgi SNAP receptor complex member 1 |
|
decreases expression | ISO | 17 | 28,804,426 | 28,853,832 | RGD:6480464 | CTD | |
| G | GPR114 | G protein-coupled receptor 114 |
|
increases expression | ISO | 16 | 57,576,601 | 57,611,101 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
decreases expression | ISO | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
multiple interactions | ISO | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
decreases activity | ISO | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
decreases response to substance | EXP | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX1 | glutathione peroxidase 1 |
|
decreases expression | EXP | 3 | 49,394,609 | 49,395,791 | RGD:6480464 | CTD | |
| G | GPX3 | glutathione peroxidase 3 (plasma) |
|
decreases expression | ISO | 5 | 150,399,999 | 150,408,554 | RGD:6480464 | CTD | |
| G | GPX7 | glutathione peroxidase 7 |
|
decreases expression | ISO | 1 | 53,068,043 | 53,074,723 | RGD:6480464 | CTD | |
| G | GRIN1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression | ISO | 9 | 140,033,609 | 140,063,214 | RGD:6480464 | CTD | |
| G | GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression | ISO | 16 | 9,847,265 | 10,276,611 | RGD:6480464 | CTD | |
| G | GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases expression | ISO | 12 | 13,714,410 | 14,133,022 | RGD:6480464 | CTD | |
| G | GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
increases expression | ISO | 17 | 72,838,168 | 72,856,007 | RGD:6480464 | CTD | |
| G | GRPR | gastrin-releasing peptide receptor |
|
decreases expression | ISO | X | 16,141,424 | 16,171,641 | RGD:6480464 | CTD | |
| G | GRWD1 | glutamate-rich WD repeat containing 1 |
|
decreases expression | ISO | 19 | 48,949,030 | 48,957,164 | RGD:6480464 | CTD | |
| G | GSK3B | glycogen synthase kinase 3 beta |
|
increases expression | ISO | 3 | 119,540,800 | 119,813,264 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
increases expression | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSS | glutathione synthetase |
|
increases expression | ISO | 20 | 33,516,236 | 33,543,601 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
increases expression | ISO | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
increases expression | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA4 | glutathione S-transferase alpha 4 |
|
increases expression | ISO | 6 | 52,842,746 | 52,860,178 | RGD:6480464 | CTD | |
| G | GSTK1 | glutathione S-transferase kappa 1 |
|
decreases expression | ISO | 7 | 142,960,522 | 142,966,222 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
decreases activity | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
decreases expression | EXP | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM5 | glutathione S-transferase mu 5 |
|
decreases expression | ISO | 1 | 110,254,864 | 110,260,890 | RGD:6480464 | CTD | |
| G | GSTO1 | glutathione S-transferase omega 1 |
|
increases expression | ISO | 10 | 106,013,952 | 106,027,222 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
affects response to substance | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
multiple interactions | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | HDAC1 | histone deacetylase 1 |
|
decreases expression | ISO | 1 | 32,757,708 | 32,799,224 | RGD:6480464 | CTD | |
| G | HECA | headcase homolog (Drosophila) |
|
increases expression | ISO | 6 | 139,456,249 | 139,501,946 | RGD:6480464 | CTD | |
| G | HES1 | hairy and enhancer of split 1, (Drosophila) |
|
affects expression | ISO | 3 | 193,853,931 | 193,856,401 | RGD:6480464 | CTD | |
| G | HES3 | hairy and enhancer of split 3 (Drosophila) |
|
affects expression | ISO | 1 | 6,304,252 | 6,305,638 | RGD:6480464 | CTD | |
| G | HES5 | hairy and enhancer of split 5 (Drosophila) |
|
affects expression | ISO | 1 | 2,460,184 | 2,461,684 | RGD:6480464 | CTD | |
| G | HIST1H3G | histone cluster 1, H3g |
|
decreases expression | ISO | 6 | 26,271,146 | 26,271,612 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HOXB1 | homeobox B1 |
|
increases expression | ISO | 17 | 46,606,807 | 46,608,272 | RGD:6480464 | CTD | |
| G | HOXB4 | homeobox B4 |
|
decreases expression | ISO | 17 | 46,652,869 | 46,655,743 | RGD:6480464 | CTD | |
| G | HOXB4 | homeobox B4 |
|
increases expression | EXP | 17 | 46,652,869 | 46,655,743 | RGD:6480464 | CTD | |
| G | HPGD | hydroxyprostaglandin dehydrogenase 15-(NAD) |
|
affects expression | ISO | 4 | 175,411,328 | 175,444,049 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
increases expression | ISO | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPA1A | heat shock 70kDa protein 1A |
|
increases expression | ISO | 6 | 31,783,291 | 31,785,719 | RGD:6480464 | CTD | |
| G | HSPB1 | heat shock 27kDa protein 1 |
|
increases expression | ISO | 7 | 75,931,875 | 75,933,614 | RGD:6480464 | CTD | |
| G | HSPB6 | heat shock protein, alpha-crystallin-related, B6 |
|
increases expression | ISO | 19 | 36,245,467 | 36,247,930 | RGD:6480464 | CTD | |
| G | ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
|
increases expression | ISO | 1 | 23,884,421 | 23,886,285 | RGD:6480464 | CTD | |
| G | IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble |
|
decreases expression | ISO | 2 | 209,100,953 | 209,119,806 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
decreases expression | ISO | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IGF1R | insulin-like growth factor 1 receptor |
|
affects expression | ISO | 15 | 99,192,761 | 99,507,759 | RGD:6480464 | CTD | |
| G | IGHM | immunoglobulin heavy constant mu | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
increases expression | ISO | 8 | 42,128,820 | 42,190,171 | RGD:6480464 | CTD | |
| G | IL10RB | interleukin 10 receptor, beta |
|
increases expression | ISO | 21 | 34,638,665 | 34,669,539 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
decreases expression | EXP | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL4R | interleukin 4 receptor |
|
increases expression | ISO | 16 | 27,325,230 | 27,376,099 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
increases secretion | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | INO80C | INO80 complex subunit C |
|
decreases expression | ISO | 18 | 33,048,291 | 33,077,955 | RGD:6480464 | CTD | |
| G | INSIG1 | insulin induced gene 1 |
|
decreases expression | ISO | 7 | 155,089,486 | 155,101,945 | RGD:6480464 | CTD | |
| G | IRS2 | insulin receptor substrate 2 |
|
affects expression | ISO | 13 | 110,406,184 | 110,438,914 | RGD:6480464 | CTD | |
| G | IRX5 | iroquois homeobox 5 |
|
affects expression | ISO | 16 | 54,965,111 | 54,968,397 | RGD:6480464 | CTD | |
| G | KCTD14 | potassium channel tetramerisation domain containing 14 |
|
decreases expression | ISO | 11 | 77,726,761 | 77,734,320 | RGD:6480464 | CTD | |
| G | KIDINS220 | kinase D-interacting substrate, 220kDa |
|
increases expression | ISO | 2 | 8,868,987 | 8,977,755 | RGD:6480464 | CTD | |
| G | KIF5C | kinesin family member 5C |
|
affects expression | ISO | 2 2 |
149,793,796 149,632,792 |
149,883,273 149,686,923 |
RGD:6480464 | CTD | |
| G | LHB | luteinizing hormone beta polypeptide |
|
multiple interactions | ISO | 19 | 49,519,237 | 49,520,347 | RGD:6480464 | CTD | |
| G | LHB | luteinizing hormone beta polypeptide |
|
affects secretion | ISO | 19 | 49,519,237 | 49,520,347 | RGD:6480464 | CTD | |
| G | LHX2 | LIM homeobox 2 |
|
affects expression | ISO | 9 | 126,773,889 | 126,795,442 | RGD:6480464 | CTD | |
| G | LNX1 | ligand of numb-protein X 1, E3 ubiquitin protein ligase |
|
decreases expression | ISO | 4 | 54,326,437 | 54,457,753 | RGD:6480464 | CTD | |
| G | LRP4 | low density lipoprotein receptor-related protein 4 |
|
affects expression | ISO | 11 | 46,878,268 | 46,940,173 | RGD:6480464 | CTD | |
| G | LYSMD2 | LysM, putative peptidoglycan-binding, domain containing 2 |
|
decreases expression | ISO | 15 | 52,015,261 | 52,043,650 | RGD:6480464 | CTD | |
| G | MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) |
|
increases expression | ISO | 17 | 79,876,145 | 79,885,587 | RGD:6480464 | CTD | |
| G | MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression | ISO | 7 | 1,570,368 | 1,582,679 | RGD:6480464 | CTD | |
| G | MAN2A1 | mannosidase, alpha, class 2A, member 1 |
|
affects expression | ISO | 5 | 109,025,156 | 109,203,429 | RGD:6480464 | CTD | |
| G | MAP2 | microtubule-associated protein 2 |
|
decreases expression | ISO | 2 | 210,288,771 | 210,598,834 | RGD:6480464 | CTD | |
| G | MAP2 | microtubule-associated protein 2 |
|
decreases expression | EXP | 2 | 210,288,771 | 210,598,834 | RGD:6480464 | CTD | |
| G | MAP2 | microtubule-associated protein 2 |
|
decreases expression | ISO | 2 | 210,288,771 | 210,598,834 | RGD:6480464 | CTD | |
| G | MAP2K1 | mitogen-activated protein kinase kinase 1 |
|
affects expression | ISO | 15 | 66,679,211 | 66,783,882 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
affects expression | ISO | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK15 | mitogen-activated protein kinase 15 |
|
increases expression | ISO | 8 | 144,798,507 | 144,804,633 | RGD:6480464 | CTD | |
| G | MAPT | microtubule-associated protein tau |
|
increases expression | ISO | 17 | 43,971,748 | 44,105,700 | RGD:6480464 | CTD | |
| G | MAPT | microtubule-associated protein tau |
|
multiple interactions | ISO | 17 | 43,971,748 | 44,105,700 | RGD:6480464 | CTD | |
| G | MAPT | microtubule-associated protein tau |
|
decreases expression | ISO | 17 | 43,971,748 | 44,105,700 | RGD:6480464 | CTD | |
| G | MARCH11 | membrane-associated ring finger (C3HC4) 11 |
|
decreases expression | ISO | 5 | 16,067,474 | 16,179,897 | RGD:6480464 | CTD | |
| G | MARCH11 | membrane-associated ring finger (C3HC4) 11 |
|
decreases expression | ISO | 5 | 16,067,474 | 16,179,897 | RGD:6480464 | CTD | |
| G | MBNL3 | muscleblind-like splicing regulator 3 |
|
affects expression | ISO | X | 131,503,342 | 131,623,996 | RGD:6480464 | CTD | |
| G | MGST1 | microsomal glutathione S-transferase 1 |
|
increases expression | ISO | 12 | 16,500,076 | 16,530,123 | RGD:6480464 | CTD | |
| G | MMP10 | matrix metallopeptidase 10 (stromelysin 2) |
|
increases expression | ISO | 11 | 102,641,233 | 102,651,359 | RGD:6480464 | CTD | |
| G | MMP13 | matrix metallopeptidase 13 (collagenase 3) |
|
increases expression | ISO | 11 | 102,813,721 | 102,826,463 | RGD:6480464 | CTD | |
| G | MOGAT1 | monoacylglycerol O-acyltransferase 1 |
|
decreases expression | ISO | 2 | 223,536,457 | 223,574,649 | RGD:6480464 | CTD | |
| G | MOGAT1 | monoacylglycerol O-acyltransferase 1 |
|
decreases expression | ISO | 2 | 223,536,457 | 223,574,649 | RGD:6480464 | CTD | |
| G | MRPL19 | mitochondrial ribosomal protein L19 |
|
decreases expression | ISO | 2 | 75,873,909 | 75,889,334 | RGD:6480464 | CTD | |
| G | MT1A | metallothionein 1A |
|
increases expression | ISO | 16 | 56,672,578 | 56,673,999 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | ISO | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MTHFD2L | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
|
decreases expression | ISO | 4 | 75,023,829 | 75,168,816 | RGD:6480464 | CTD | |
| G | MTRR | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
decreases expression | ISO | 5 | 7,869,217 | 7,901,237 | RGD:6480464 | CTD | |
| G | MUTYH | mutY homolog (E. coli) |
|
increases expression | ISO | 1 | 45,794,914 | 45,806,142 | RGD:6480464 | CTD | |
| G | NDN | necdin, melanoma antigen (MAGE) family member |
|
affects expression | ISO | 15 | 23,930,554 | 23,932,450 | RGD:6480464 | CTD | |
| G | NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
increases expression | ISO | 18 | 55,711,610 | 56,068,772 | RGD:6480464 | CTD | |
| G | NEFH | neurofilament, heavy polypeptide |
|
decreases expression | ISO | 22 | 29,876,181 | 29,887,279 | RGD:6480464 | CTD | |
| G | NEFL | neurofilament, light polypeptide |
|
affects expression | ISO | 8 | 24,808,468 | 24,814,131 | RGD:6480464 | CTD | |
| G | NEFL | neurofilament, light polypeptide |
|
decreases expression | ISO | 8 | 24,808,468 | 24,814,131 | RGD:6480464 | CTD | |
| G | NELL2 | NEL-like 2 (chicken) |
|
increases expression | ISO | 12 | 44,902,058 | 45,307,711 | RGD:6480464 | CTD | |
| G | NES | nestin |
|
affects expression | ISO | 1 | 156,638,555 | 156,647,189 | RGD:6480464 | CTD | |
| G | NES | nestin |
|
increases expression | ISO | 1 | 156,638,555 | 156,647,189 | RGD:6480464 | CTD | |
| G | NEUROG2 | neurogenin 2 |
|
affects expression | ISO | 4 | 113,434,672 | 113,437,328 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
affects localization | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
decreases response to substance | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
affects localization | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NKX6-1 | NK6 homeobox 1 |
|
affects expression | ISO | 4 | 85,414,436 | 85,419,387 | RGD:6480464 | CTD | |
| G | NKX6-2 | NK6 homeobox 2 |
|
affects expression | ISO | 10 | 134,598,320 | 134,599,537 | RGD:6480464 | CTD | |
| G | NMUR1 | neuromedin U receptor 1 |
|
decreases expression | ISO | 2 | 232,387,871 | 232,395,182 | RGD:6480464 | CTD | |
| G | NODAL | nodal growth differentiation factor |
|
increases expression | EXP | 10 | 72,191,692 | 72,201,465 | RGD:6480464 | CTD | |
| G | NOTCH1 | notch 1 |
|
affects expression | ISO | 9 | 139,388,896 | 139,440,238 | RGD:6480464 | CTD | |
| G | NPY4R | neuropeptide Y receptor Y4 |
|
decreases expression | ISO | 10 | 47,083,534 | 47,088,320 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO2 | NAD(P)H dehydrogenase, quinone 2 |
|
decreases expression | ISO | 6 | 3,000,067 | 3,019,994 | RGD:6480464 | CTD | |
| G | NR2F6 | nuclear receptor subfamily 2, group F, member 6 |
|
affects expression | ISO | 19 | 17,342,694 | 17,356,151 | RGD:6480464 | CTD | |
| G | NR4A2 | nuclear receptor subfamily 4, group A, member 2 |
|
affects expression | ISO | 2 | 157,180,944 | 157,189,287 | RGD:6480464 | CTD | |
| G | NRF1 | nuclear respiratory factor 1 |
|
decreases expression | ISO | 7 | 129,251,555 | 129,396,922 | RGD:6480464 | CTD | |
| G | NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 |
|
affects expression | ISO | 9 | 87,283,466 | 87,638,505 | RGD:6480464 | CTD | |
| G | NTSR1 | neurotensin receptor 1 (high affinity) |
|
decreases expression | ISO | 20 | 61,340,189 | 61,394,123 | RGD:6480464 | CTD | |
| G | NUF2 | NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
decreases expression | ISO | 1 | 163,291,723 | 163,325,553 | RGD:6480464 | CTD | |
| G | OLIG1 | oligodendrocyte transcription factor 1 |
|
increases expression | ISO | 21 | 34,442,450 | 34,444,728 | RGD:6480464 | CTD | |
| G | OLIG1 | oligodendrocyte transcription factor 1 |
|
increases expression | EXP | 21 | 34,442,450 | 34,444,728 | RGD:6480464 | CTD | |
| G | OLIG2 | oligodendrocyte lineage transcription factor 2 |
|
increases expression | EXP | 21 | 34,398,216 | 34,401,504 | RGD:6480464 | CTD | |
| G | OLIG2 | oligodendrocyte lineage transcription factor 2 |
|
decreases expression | ISO | 21 | 34,398,216 | 34,401,504 | RGD:6480464 | CTD | |
| G | OOEP | oocyte expressed protein |
|
affects expression | ISO | 6 | 74,078,278 | 74,079,515 | RGD:6480464 | CTD | |
| G | OSGIN1 | oxidative stress induced growth inhibitor 1 |
|
increases expression | ISO | 16 | 83,986,827 | 83,999,937 | RGD:6480464 | CTD | |
| G | OVOL2 | ovo-like 2 (Drosophila) |
|
affects expression | ISO | 20 | 18,004,796 | 18,038,521 | RGD:6480464 | CTD | |
| G | OXSR1 | oxidative-stress responsive 1 |
|
increases expression | ISO | 3 | 38,207,026 | 38,296,979 | RGD:6480464 | CTD | |
| G | PARK2 | parkinson protein 2, E3 ubiquitin protein ligase (parkin) |
|
increases expression | ISO | 6 | 161,768,590 | 163,148,834 | RGD:6480464 | CTD | |
| G | PARP1 | poly (ADP-ribose) polymerase 1 |
|
increases cleavage | EXP | 1 | 226,548,392 | 226,595,801 | RGD:6480464 | CTD | |
| G | PAX3 | paired box 3 |
|
affects expression | ISO | 2 | 223,064,606 | 223,163,715 | RGD:6480464 | CTD | |
| G | PAX6 | paired box 6 |
|
affects expression | ISO | 11 | 31,806,340 | 31,839,509 | RGD:6480464 | CTD | |
| G | PAX6 | paired box 6 |
|
decreases expression | EXP | 11 | 31,806,340 | 31,839,509 | RGD:6480464 | CTD | |
| G | PCDH8 | protocadherin 8 |
|
affects expression | ISO | 13 | 53,418,109 | 53,422,775 | RGD:6480464 | CTD | |
| G | PCSK9 | proprotein convertase subtilisin/kexin type 9 |
|
affects expression | ISO | 1 | 55,505,149 | 55,530,526 | RGD:6480464 | CTD | |
| G | PDE11A | phosphodiesterase 11A |
|
decreases expression | ISO | 2 | 178,487,977 | 178,973,066 | RGD:6480464 | CTD | |
| G | PDE5A | phosphodiesterase 5A, cGMP-specific |
|
decreases expression | ISO | 4 | 120,415,550 | 120,549,981 | RGD:6480464 | CTD | |
| G | PDHX | pyruvate dehydrogenase complex, component X |
|
decreases expression | ISO | 11 | 34,937,677 | 35,017,675 | RGD:6480464 | CTD | |
| G | PDHX | pyruvate dehydrogenase complex, component X |
|
decreases expression | ISO | 11 | 34,937,677 | 35,017,675 | RGD:6480464 | CTD | |
| G | PGR | progesterone receptor |
|
increases expression | ISO | 11 | 100,900,355 | 101,000,544 | RGD:6480464 | CTD | |
| G | PIGR | polymeric immunoglobulin receptor |
|
increases expression | ISO | 1 | 207,101,867 | 207,119,811 | RGD:6480464 | CTD | |
| G | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
affects expression | ISO | 5 | 67,511,584 | 67,597,649 | RGD:6480464 | CTD | |
| G | PITX2 | paired-like homeodomain 2 |
|
decreases expression | ISO | 4 | 111,538,579 | 111,563,279 | RGD:6480464 | CTD | |
| G | POU4F2 | POU class 4 homeobox 2 |
|
affects expression | ISO | 4 | 147,560,045 | 147,563,623 | RGD:6480464 | CTD | |
| G | POU5F1 | POU class 5 homeobox 1 |
|
increases expression | EXP | 6 | 31,132,114 | 31,138,451 | RGD:6480464 | CTD | |
| G | PRDM1 | PR domain containing 1, with ZNF domain |
|
affects expression | ISO | 6 | 106,534,195 | 106,557,814 | RGD:6480464 | CTD | |
| G | PRDX1 | peroxiredoxin 1 |
|
increases expression | ISO | 1 | 45,976,707 | 45,988,562 | RGD:6480464 | CTD | |
| G | PRDX1 | peroxiredoxin 1 |
|
increases expression | ISO | 1 | 45,976,707 | 45,988,562 | RGD:6480464 | CTD | |
| G | PROKR1 | prokineticin receptor 1 |
|
decreases expression | ISO | 2 | 68,872,954 | 68,882,708 | RGD:6480464 | CTD | |
| G | PRORSD1P | prolyl-tRNA synthetase associated domain containing 1, pseudogene |
|
decreases expression | ISO | 2 | 55,509,455 | 55,511,608 | RGD:6480464 | CTD | |
| G | PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 |
|
decreases expression | ISO | 6 | 32,808,494 | 32,812,712 | RGD:6480464 | CTD | |
| G | PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 |
|
decreases expression | ISO | 6 | 32,821,938 | 32,827,628 | RGD:6480464 | CTD | |
| G | PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
|
decreases expression | ISO | 14 | 24,605,378 | 24,608,176 | RGD:6480464 | CTD | |
| G | PTGFRN | prostaglandin F2 receptor inhibitor |
|
increases expression | ISO | 1 | 117,452,689 | 117,532,972 | RGD:6480464 | CTD | |
| G | PTPLA | protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
|
decreases expression | ISO | 10 | 17,631,958 | 17,659,373 | RGD:6480464 | CTD | |
| G | PTTG1IP | pituitary tumor-transforming 1 interacting protein |
|
decreases expression | ISO | 21 | 46,269,500 | 46,293,818 | RGD:6480464 | CTD | |
| G | PWP2 | PWP2 periodic tryptophan protein homolog (yeast) |
|
decreases expression | ISO | 21 | 45,527,208 | 45,551,063 | RGD:6480464 | CTD | |
| G | QRSL1 | glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 |
|
decreases expression | ISO | 6 | 107,077,441 | 107,116,292 | RGD:6480464 | CTD | |
| G | RAB3IP | RAB3A interacting protein |
|
increases expression | ISO | 12 | 70,132,631 | 70,216,984 | RGD:6480464 | CTD | |
| G | RABGEF1 | RAB guanine nucleotide exchange factor (GEF) 1 |
|
decreases expression | ISO | 7 | 66,205,643 | 66,276,451 | RGD:6480464 | CTD | |
| G | RABL3 | RAB, member of RAS oncogene family-like 3 |
|
decreases expression | ISO | 3 | 120,405,528 | 120,461,384 | RGD:6480464 | CTD | |
| G | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
decreases expression | ISO | 7 | 6,414,126 | 6,443,598 | RGD:6480464 | CTD | |
| G | RBM12 | RNA binding motif protein 12 |
|
decreases expression | ISO | 20 | 34,236,847 | 34,252,878 | RGD:6480464 | CTD | |
| G | RERG | RAS-like, estrogen-regulated, growth inhibitor |
|
affects expression | ISO | 12 | 15,260,716 | 15,374,411 | RGD:6480464 | CTD | |
| G | RHEBL1 | Ras homolog enriched in brain like 1 |
|
increases expression | ISO | 12 | 49,458,468 | 49,463,775 | RGD:6480464 | CTD | |
| G | RHOA | ras homolog family member A |
|
decreases response to substance | ISO | 3 | 49,396,578 | 49,449,526 | RGD:6480464 | CTD | |
| G | RHOA | ras homolog family member A |
|
decreases expression | ISO | 3 | 49,396,578 | 49,449,526 | RGD:6480464 | CTD | |
| G | RIMS2 | regulating synaptic membrane exocytosis 2 |
|
decreases expression | ISO | 8 | 104,512,976 | 105,266,656 | RGD:6480464 | CTD | |
| G | RIN2 | Ras and Rab interactor 2 |
|
decreases expression | ISO | 20 | 19,867,165 | 19,983,103 | RGD:6480464 | CTD | |
| G | RNF166 | ring finger protein 166 |
|
increases expression | ISO | 16 | 88,762,903 | 88,772,829 | RGD:6480464 | CTD | |
| G | ROBO2 | roundabout, axon guidance receptor, homolog 2 (Drosophila) |
|
affects expression | ISO | 3 | 75,955,845 | 77,699,115 | RGD:6480464 | CTD | |
| G | ROBO3 | roundabout, axon guidance receptor, homolog 3 (Drosophila) |
|
affects expression | ISO | 11 | 124,735,305 | 124,751,370 | RGD:6480464 | CTD | |
| G | RPIA | ribose 5-phosphate isomerase A |
|
decreases expression | ISO | 2 | 88,991,176 | 89,050,452 | RGD:6480464 | CTD | |
| G | RTN4RL2 | reticulon 4 receptor-like 2 |
|
affects expression | ISO | 11 | 57,228,339 | 57,244,384 | RGD:6480464 | CTD | |
| G | RWDD2B | RWD domain containing 2B |
|
decreases expression | ISO | 21 | 30,378,080 | 30,391,685 | RGD:6480464 | CTD | |
| G | S100B | S100 calcium binding protein B |
|
increases expression | ISO | 21 | 48,018,531 | 48,025,035 | RGD:6480464 | CTD | |
| G | S1PR5 | sphingosine-1-phosphate receptor 5 |
|
affects expression | ISO | 19 | 10,623,418 | 10,628,668 | RGD:6480464 | CTD | |
| G | SAA1 | serum amyloid A1 |
|
increases expression | ISO | 11 | 18,287,808 | 18,291,524 | RGD:6480464 | CTD | |
| G | SAE1 | SUMO1 activating enzyme subunit 1 |
|
decreases expression | ISO | 19 | 47,634,080 | 47,713,893 | RGD:6480464 | CTD | |
| G | SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression | ISO | 18 | 61,554,939 | 61,571,124 | RGD:6480464 | CTD | |
| G | SHARPIN | SHANK-associated RH domain interactor |
|
increases expression | ISO | 8 | 145,153,536 | 145,159,140 | RGD:6480464 | CTD | |
| G | SHH | sonic hedgehog |
|
decreases expression | ISO | 7 | 155,595,558 | 155,604,967 | RGD:6480464 | CTD | |
| G | SKP1 | S-phase kinase-associated protein 1 |
|
increases expression | ISO | 5 | 133,492,082 | 133,512,724 | RGD:6480464 | CTD | |
| G | SLC17A5 | solute carrier family 17 (anion/sugar transporter), member 5 |
|
increases expression | ISO | 6 | 74,303,102 | 74,363,737 | RGD:6480464 | CTD | |
| G | SLC22A12 | solute carrier family 22 (organic anion/urate transporter), member 12 |
|
decreases expression | ISO | 11 | 64,358,282 | 64,369,820 | RGD:6480464 | CTD | |
| G | SLC24A6 | solute carrier family 24 (sodium/lithium/calcium exchanger), member 6 |
|
increases expression | ISO | 12 | 113,736,571 | 113,772,925 | RGD:6480464 | CTD | |
| G | SLC25A37 | solute carrier family 25 (mitochondrial iron transporter), member 37 |
|
decreases expression | ISO | 8 | 23,386,363 | 23,430,063 | RGD:6480464 | CTD | |
| G | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
|
increases expression | ISO | 1 | 43,391,046 | 43,424,847 | RGD:6480464 | CTD | |
| G | SLC30A10 | solute carrier family 30, member 10 |
|
increases expression | ISO | 1 | 220,087,606 | 220,101,993 | RGD:6480464 | CTD | |
| G | SLC30A7 | solute carrier family 30 (zinc transporter), member 7 |
|
decreases expression | ISO | 1 | 101,361,632 | 101,447,311 | RGD:6480464 | CTD | |
| G | SLC7A11 | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions | ISO | 4 | 139,085,248 | 139,163,503 | RGD:6480464 | CTD | |
| G | SLITRK5 | SLIT and NTRK-like family, member 5 |
|
affects expression | ISO | 13 | 88,324,870 | 88,331,871 | RGD:6480464 | CTD | |
| G | SMAD3 | SMAD family member 3 |
|
increases expression | ISO | 15 | 67,358,195 | 67,487,533 | RGD:6480464 | CTD | |
| G | SMAD4 | SMAD family member 4 |
|
increases expression | ISO | 18 | 48,556,583 | 48,611,412 | RGD:6480464 | CTD | |
| G | SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
affects expression | ISO | 19 | 11,071,598 | 11,172,958 | RGD:6480464 | CTD | |
| G | SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 |
|
increases expression | ISO | 7 | 98,625,058 | 98,741,743 | RGD:6480464 | CTD | |
| G | SNCA | synuclein, alpha (non A4 component of amyloid precursor) |
|
decreases expression | ISO | 4 | 90,645,250 | 90,759,447 | RGD:6480464 | CTD | |
| G | SNCAIP | synuclein, alpha interacting protein |
|
increases expression | ISO | 5 | 121,647,820 | 121,799,794 | RGD:6480464 | CTD | |
| G | SNX3 | sorting nexin 3 |
|
increases expression | ISO | 6 | 108,532,717 | 108,582,464 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
increases expression | ISO | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SOX10 | SRY (sex determining region Y)-box 10 |
|
decreases expression | ISO | 22 | 38,368,319 | 38,380,539 | RGD:6480464 | CTD | |
| G | SQSTM1 | sequestosome 1 |
|
increases expression | ISO | 5 | 179,233,388 | 179,265,078 | RGD:6480464 | CTD | |
| G | SSTR3 | somatostatin receptor 3 |
|
decreases expression | ISO | 22 | 37,602,245 | 37,608,353 | RGD:6480464 | CTD | |
| G | STARD4 | StAR-related lipid transfer (START) domain containing 4 |
|
decreases expression | ISO | 5 | 110,834,022 | 110,848,157 | RGD:6480464 | CTD | |
| G | STIM1 | stromal interaction molecule 1 |
|
increases expression | ISO | 11 | 3,876,933 | 4,114,440 | RGD:6480464 | CTD | |
| G | STMN3 | stathmin-like 3 |
|
affects expression | ISO | 20 | 62,271,061 | 62,284,780 | RGD:6480464 | CTD | |
| G | SYP | synaptophysin |
|
decreases expression | ISO | X | 49,044,265 | 49,056,661 | RGD:6480464 | CTD | |
| G | TACR2 | tachykinin receptor 2 |
|
decreases expression | ISO | 10 | 71,163,958 | 71,176,674 | RGD:6480464 | CTD | |
| G | TACR3 | tachykinin receptor 3 |
|
decreases expression | ISO | 4 | 104,510,625 | 104,640,973 | RGD:6480464 | CTD | |
| G | TAF1D | TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa |
|
decreases expression | ISO | 11 | 93,469,095 | 93,474,703 | RGD:6480464 | CTD | |
| G | TBRG4 | transforming growth factor beta regulator 4 |
|
decreases expression | ISO | 7 | 45,139,699 | 45,151,346 | RGD:6480464 | CTD | |
| G | TBX3 | T-box 3 |
|
affects expression | ISO | 12 | 115,108,059 | 115,121,969 | RGD:6480464 | CTD | |
| G | TBX6 | T-box 6 |
|
decreases expression | ISO | 16 | 30,097,114 | 30,103,205 | RGD:6480464 | CTD | |
| G | TCF15 | transcription factor 15 (basic helix-loop-helix) |
|
affects expression | ISO | 20 | 584,637 | 590,910 | RGD:6480464 | CTD | |
| G | TDGF1 | teratocarcinoma-derived growth factor 1 |
|
affects expression | ISO | 3 | 46,616,045 | 46,623,953 | RGD:6480464 | CTD | |
| G | TEAD4 | TEA domain family member 4 |
|
affects expression | ISO | 12 | 3,068,478 | 3,149,842 | RGD:6480464 | CTD | |
| G | TGFB1 | transforming growth factor, beta 1 |
|
decreases expression | ISO | 19 | 41,836,812 | 41,859,831 | RGD:6480464 | CTD | |
| G | TH | tyrosine hydroxylase |
|
decreases expression | ISO | 11 | 2,185,159 | 2,193,035 | RGD:6480464 | CTD | |
| G | TH | tyrosine hydroxylase |
|
multiple interactions | ISO | 11 | 2,185,159 | 2,193,035 | RGD:6480464 | CTD | |
| G | TJP3 | tight junction protein 3 |
|
decreases expression | ISO | 19 | 3,708,335 | 3,750,811 | RGD:6480464 | CTD | |
| G | TLCD1 | TLC domain containing 1 |
|
decreases expression | ISO | 17 | 27,051,366 | 27,053,949 | RGD:6480464 | CTD | |
| G | TMED5 | transmembrane emp24 protein transport domain containing 5 |
|
decreases expression | ISO | 1 | 93,615,299 | 93,646,246 | RGD:6480464 | CTD | |
| G | TMEM69 | transmembrane protein 69 |
|
decreases expression | ISO | 1 | 46,153,847 | 46,160,108 | RGD:6480464 | CTD | |
| G | TNFAIP8L1 | tumor necrosis factor, alpha-induced protein 8-like 1 |
|
decreases expression | ISO | 19 | 4,639,527 | 4,655,580 | RGD:6480464 | CTD | |
| G | TNFRSF19 | tumor necrosis factor receptor superfamily, member 19 |
|
increases expression | ISO | 13 | 24,144,509 | 24,250,244 | RGD:6480464 | CTD | |
| G | TNKS2 | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 |
|
increases expression | ISO | 10 | 93,558,151 | 93,625,232 | RGD:6480464 | CTD | |
| G | TOE1 | target of EGR1, member 1 (nuclear) |
|
decreases expression | ISO | 1 | 45,805,342 | 45,809,650 | RGD:6480464 | CTD | |
| G | TOP2A | topoisomerase (DNA) II alpha 170kDa |
|
decreases expression | ISO | 17 | 38,544,773 | 38,574,202 | RGD:6480464 | CTD | |
| G | TP63 | tumor protein p63 |
|
affects expression | ISO | 3 | 189,349,216 | 189,615,068 | RGD:6480464 | CTD | |
| G | TPCN2 | two pore segment channel 2 |
|
decreases expression | ISO | 11 | 68,816,350 | 68,858,072 | RGD:6480464 | CTD | |
| G | TPRA1 | transmembrane protein, adipocyte asscociated 1 |
|
increases expression | ISO | 3 | 127,291,908 | 127,309,568 | RGD:6480464 | CTD | |
| G | TRPC1 | transient receptor potential cation channel, subfamily C, member 1 |
|
decreases expression | ISO | 3 | 142,443,266 | 142,526,730 | RGD:6480464 | CTD | |
| G | TSC1 | tuberous sclerosis 1 |
|
affects expression | ISO | 9 | 135,766,735 | 135,820,020 | RGD:6480464 | CTD | |
| G | TTC3 | tetratricopeptide repeat domain 3 |
|
increases expression | ISO | 21 | 38,445,571 | 38,575,408 | RGD:6480464 | CTD | |
| G | TTC4 | tetratricopeptide repeat domain 4 |
|
decreases expression | ISO | 1 | 55,181,495 | 55,208,330 | RGD:6480464 | CTD | |
| G | TUBB3 | tubulin, beta 3 class III |
|
decreases expression | ISO | 16 | 89,988,417 | 90,002,505 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
decreases activity | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TYMS | thymidylate synthetase |
|
decreases expression | ISO | 18 | 657,604 | 673,499 | RGD:6480464 | CTD | |
| G | TYW5 | tRNA-yW synthesizing protein 5 |
|
decreases expression | ISO | 2 | 200,793,634 | 200,820,459 | RGD:6480464 | CTD | |
| G | UBE2C | ubiquitin-conjugating enzyme E2C |
|
decreases expression | ISO | 20 | 44,441,255 | 44,445,596 | RGD:6480464 | CTD | |
| G | UBE2E1 | ubiquitin-conjugating enzyme E2E 1 |
|
increases expression | ISO | 3 | 23,847,384 | 23,933,131 | RGD:6480464 | CTD | |
| G | UBE2F | ubiquitin-conjugating enzyme E2F (putative) |
|
increases expression | ISO | 2 | 238,875,587 | 238,951,423 | RGD:6480464 | CTD | |
| G | UBE2I | ubiquitin-conjugating enzyme E2I |
|
increases expression | ISO | 16 | 1,359,154 | 1,377,019 | RGD:6480464 | CTD | |
| G | UBE2J1 | ubiquitin-conjugating enzyme E2, J1 |
|
increases expression | ISO | 6 | 90,036,344 | 90,062,619 | RGD:6480464 | CTD | |
| G | UBE2K | ubiquitin-conjugating enzyme E2K |
|
increases expression | ISO | 4 | 39,699,664 | 39,784,412 | RGD:6480464 | CTD | |
| G | UBE2L6 | ubiquitin-conjugating enzyme E2L 6 |
|
decreases expression | ISO | 11 | 57,319,128 | 57,335,803 | RGD:6480464 | CTD | |
| G | UBE2T | ubiquitin-conjugating enzyme E2T (putative) |
|
decreases expression | ISO | 1 | 202,300,785 | 202,311,094 | RGD:6480464 | CTD | |
| G | UBE2W | ubiquitin-conjugating enzyme E2W (putative) |
|
increases expression | ISO | 8 | 74,692,332 | 74,791,145 | RGD:6480464 | CTD | |
| G | UBIAD1 | UbiA prenyltransferase domain containing 1 |
|
decreases expression | ISO | 1 | 11,333,255 | 11,348,491 | RGD:6480464 | CTD | |
| G | UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
increases expression | ISO | 4 | 41,258,898 | 41,270,446 | RGD:6480464 | CTD | |
| G | UFD1L | ubiquitin fusion degradation 1 like (yeast) |
|
increases expression | ISO | 22 | 19,437,464 | 19,466,738 | RGD:6480464 | CTD | |
| G | USP11 | ubiquitin specific peptidase 11 |
|
increases expression | ISO | X | 47,092,314 | 47,107,727 | RGD:6480464 | CTD | |
| G | USP38 | ubiquitin specific peptidase 38 |
|
increases expression | ISO | 4 | 144,106,070 | 144,143,141 | RGD:6480464 | CTD | |
| G | UTP18 | UTP18 small subunit (SSU) processome component homolog (yeast) |
|
decreases expression | ISO | 17 | 49,337,897 | 49,375,294 | RGD:6480464 | CTD | |
| G | VASP | vasodilator-stimulated phosphoprotein |
|
affects expression | ISO | 19 | 46,010,688 | 46,030,241 | RGD:6480464 | CTD | |
| G | VWF | von Willebrand factor |
|
affects expression | ISO | 12 | 6,058,040 | 6,233,836 | RGD:6480464 | CTD | |
| G | WDR43 | WD repeat domain 43 |
|
decreases expression | ISO | 2 | 29,117,533 | 29,171,080 | RGD:6480464 | CTD | |
| G | WEE1 | WEE1 homolog (S. pombe) |
|
decreases expression | ISO | 11 | 9,595,228 | 9,611,314 | RGD:6480464 | CTD | |
| G | WNT1 | wingless-type MMTV integration site family, member 1 |
|
affects expression | ISO | 12 | 49,372,236 | 49,376,396 | RGD:6480464 | CTD | |
| G | WNT1 | wingless-type MMTV integration site family, member 1 |
|
decreases expression | ISO | 12 | 49,372,236 | 49,376,396 | RGD:6480464 | CTD | |
| G | XIRP1 | xin actin-binding repeat containing 1 |
|
affects expression | ISO | 3 | 39,224,706 | 39,234,085 | RGD:6480464 | CTD | |
| G | XKR5 | XK, Kell blood group complex subunit-related family, member 5 |
|
decreases expression | ISO | 8 | 6,666,038 | 6,693,166 | RGD:6480464 | CTD | |
| G | ZKSCAN5 | zinc finger with KRAB and SCAN domains 5 |
|
decreases expression | ISO | 7 | 99,102,273 | 99,131,445 | RGD:6480464 | CTD | |
| G | ZNF175 | zinc finger protein 175 |
|
decreases expression | ISO | 19 | 52,074,531 | 52,092,991 | RGD:6480464 | CTD | |
| G | ZNF276 | zinc finger protein 276 |
|
decreases expression | ISO | 16 | 89,787,393 | 89,807,333 | RGD:6480464 | CTD | |
| G | ZNF292 | zinc finger protein 292 |
|
decreases expression | ISO | 6 | 87,865,269 | 87,973,406 | RGD:6480464 | CTD | |
| G | ZNF553 | zinc finger protein 553 | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | ZNF558 | zinc finger protein 558 |
|
increases expression | ISO | 19 | 8,920,382 | 8,933,565 | RGD:6480464 | CTD | |
p-chloromercuribenzenesulfonic acid
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | AQP1 | aquaporin 1 (Colton blood group) |
|
decreases activity | EXP | 7 | 30,951,415 | 30,965,131 | RGD:6480464 | CTD | |
| G | CLDN2 | claudin 2 |
|
decreases activity | ISO | X | 106,143,394 | 106,174,091 | RGD:6480464 | CTD | |
| G | SLC5A6 | solute carrier family 5 (sodium-dependent vitamin transporter), member 6 |
|
multiple interactions | EXP | 2 | 27,422,455 | 27,435,175 | RGD:6480464 | CTD | |
| G | TRPC5 | transient receptor potential cation channel, subfamily C, member 5 |
|
increases activity | EXP | X | 111,017,542 | 111,326,004 | RGD:6480464 | CTD | |
p-chloromercuribenzoic acid
| |||||||||||
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | FUT8 | fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
multiple interactions | EXP | 14 | 65,877,310 | 66,210,839 | RGD:6480464 | CTD | |
| G | FUT8 | fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
decreases activity | EXP | 14 | 65,877,310 | 66,210,839 | RGD:6480464 | CTD | |
| G | SLC16A1 | solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions | EXP | 1 | 113,454,469 | 113,498,975 | RGD:6480464 | CTD | |
Term paths to the root
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term